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64 pp., ISBN 978-952-10-4919-4 (paperpack), ISBN 978-952-10-4920-0 (pdf),
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The number of drug substances in formulation development in the
pharmaceutical industry is increasing. Some of these are amorphous drugs
and have glass transition below ambient temperature, and thus they are
usually difficult to formulate and handle. One reason for this is the reduced
viscosity, related to the stickiness of the drug, that makes them complicated
to handle in unit operations. Thus, the aim in this thesis was to develop a
new processing method for a sticky amorphous model material. Furthermore,
model materials were characterised before and after formulation, using
several characterisation methods, to understand more precisely the
prerequisites for physical stability of amorphous state against crystallisation.
The model materials used were monoclinic paracetamol and citric acid
anhydrate. Amorphous materials were prepared by melt quenching or by
ethanol evaporation methods. The melt blends were found to have slightly
higher viscosity than the ethanol evaporated materials. However, melt
produced materials crystallised more easily upon consecutive shearing than
ethanol evaporated materials. The only material that did not crystallise
during shearing was a 50/50 (w/w, %) blend regardless of the preparation
method and it was physically stable at least two years in dry conditions.
Shearing at varying temperatures was established to measure the physical
stability of amorphous materials in processing and storage conditions.
The actual physical stability of the blends was better than the pure
amorphous materials at ambient temperature. Molecular mobility was not
related to the physical stability of the amorphous blends, observed as
crystallisation. Molecular mobility of the 50/50 blend derived from a spectral
linewidth as a function of temperature using solid state NMR correlated
better with the molecular mobility derived from a rheometer than that of
differential scanning calorimetry data. Based on the results obtained, the
effect of molecular interactions, thermodynamic driving force and miscibility
of the blends are discussed as the key factors to stabilise the blends.
The stickiness was found to be affected glass transition and viscosity.
Ultrasound extrusion and cutting were successfully tested to increase the
processability of sticky material. Furthermore, it was found to be possible to
process the physically stable 50/50 blend in a supercooled liquid state instead
of a glassy state. The method was not found to accelerate the crystallisation.
This may open up new possibilities to process amorphous materials that are
otherwise impossible to manufacture into solid dosage forms.
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1. Introduction
An active pharmaceutical ingredient (API) may exist in different physical
forms. The polymorphism of crystalline drugs is the main focus in solid-state
pharmacy. In crystalline polymorphs, molecules can have different internal
arrangements and conformations in the crystal lattice, and thus they have
long-range molecular order. The most stable polymorphic form has the
lowest possibility for conversion to other polymorphic forms during
processing or storage and thus it is the one formulated into a drug product.
Nowadays, metastable forms are also chosen for formulation in order to
increase solubility, for instance, and thereby bioavailability of the drug.
Amorphous materials are non-equilibrium systems and many changes in
the materials have time-dependent properties [1]. An amorphous solid has
short-range molecular order but it does not have any long-range molecular
order or packing as a crystalline form would. Typically, these regions of short-
range order have size of only a few molecular layers [2]. Amorphous
structures are observed widely in nature, where carbohydrate glasses play an
important role in the anhydrous preservation of biological systems. An
amorphous structure is common for polymeric materials, food ingredients,
peptides and proteins that are naturally amorphous, most likely owing to
their large molecular size or due to their processing.
In pharmaceutical materials, an amorphous state is common for excipients
and it increases within drug molecules, especially within biopharmaceuticals
that are also naturally amorphous or they are often formulated into an
amorphous matrix to increase chemical stability [3]. Rational drug design and
high throughput screening have changed the development of new drugs.
Specific understanding of more complex receptor structure usually results in
larger and more complex molecular structures for drugs that bind to these
receptors. New drugs are modified to suit complex receptors, and this has
increased problems in drug development, such as difficulties in crystallising
drugs [4]. Modification increases size and complexity, producing molecules
that are difficult to crystallise.
The amorphous solid state has a higher dissolution* rate (*NOTE: In this
study, the term dissolution is also used for an amorphous material although
the amorphous material mixes into liquid. The term dissolution is appropriate
for crystalline material.), higher chemical reactivity and higher water vapour
sorption than the crystalline state. This is due to increased free volume,
molecular mobility and the enthalpy of the amorphous state [2]. These
properties can have benefits. For example, rapid formation of solution is
sometimes desirable to achieve a high efficacy and a rapid absorption rate
that may increase the bioavailability of the drug [5]. The Biopharmaceutical
Classification System divides drugs into four classes depending on drug
product in vitro dissolution properties and in vivo bioavailability [6]. Poor
dissolution of drug may be the rate limiting step to absorption and hence to
bioavailability of drug. More than 40% of potent new APIs suffer from poor
-Introduction-
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solubility and thus pharmaceutical companies are interested in the
amorphous state [7]. However, the higher bioavailability or absorption rate
of the amorphous form of the drug may also cause problems. In 1980, the
crystalline form of warfarin sodium was replaced by an amorphous form to
reduce costs in hospital pharmacy. It increased the number of patients with a
loss of anticoagulation control and overall health care costs [8]. Furthermore,
the amorphous form has been observed to increase the skin permeation of
ketotifen (antiallergy drug) compared with the crystalline form when a
matrix patch is used [9].
In addition, many companies can gain patent protection for the
amorphous form of a drug and a competitive advantage against other
pharmaceutical companies. Pursuit of competitiveness is sometimes
challenging because the amorphous state is a non-equilibrium state; an
amorphous API may crystallise during storage or during a manufacturing
process [10]. One of the world’s best selling drugs, atorvastatin (Lipitor®) was
formulated as an amorphous salt but it was observed to crystallise during
phase III clinical trials [11]. This drawback delayed the launching of the drug
onto the market a few years, and the total sales of Lipitor® were worth
approximately $12.9 billion (USD) in the year 2006 [12]. There are several
patents or methods for preparing amorphous atorvastatin from different
salts by other drug companies. The new molecular API patent for atorvastatin
is valid until 07-2011. Pfizer has also patented a process to prepare
amorphous atorvastatin calcium, the same salt as in the crystalline Lipitor® on
the market [13]. It may increase the patent protection time of Lipitor®
because it is a different physical form of the drug.
In solid dosage form, other well known amorphous drugs with a low
molecular weight are e.g. quinapril hydrochloride (Accupril®), zafirlukast
(Accolate®), nelfinavir mesylate (Viracept®) and itraconazole (Sporanox®) [4].
In addition, nowadays there are many companies with products in the
pipeline that are reported to be amorphous drugs with a low molecular
weight.  The future will  show how many of these will  come to market in an
amorphous form.
Solid dispersions are one way to prepare a drug in an amorphous dosage
form. There are a few commercial drug products on the market which are
based on amorphous solid dispersion technology. These include Novartis's
soft gelatine capsule Gris-PEG®, which is based on a solid dispersion of
griseofulvin in polyethylene glycol (PEG 8000) [14]. Fujisawa's Prograf crème
is based on a solid amorphous dispersion of tacrolimus in
hydroxypropylmethylcellulose (HPMC) [15]. An amorphous drug product
called Sporanox® is sold as hard gelatine capsules and is based on an
itraconazole-HPMC solid dispersion which is coated onto sugar beads [16].
Lilly's capsule product Cesamet® is based on a solid dispersion of nabilone in
povidone [14]. The newest amorphous dispersion sold as soft gelatine
capsules, is Roche's Fortovase® containing saquinavir mesylate suspended in
glycerides [17]. Many solid dispersions are sticky and thus processing into a
solid dosage form is challenging due to stickiness [14].
-Introduction-
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The main objective of this study was to develop a processing method for a
small molecular weight model material that has a glass transition below
ambient temperature and is thus sticky. In addition, features of the material
intended to increase the physical stability of a low molecular weight binary
system are studied, including systems enhancing physical stability against
crystallisation are discussed. The literature review is focused on the scientific
literature of the amorphous state and patents for amorphous formulations
that have been accepted world wide.
-Literature review-
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2. Literature review
2.1 Processing methods to produce amorphous material
The large scale preparation of an amorphous drug is a problem for the
pharmaceutical industry at the moment [18]. In addition, there are problems
in the methods of physical characterisation of the amorphous state, because
the methods used are focused on observing the lack of crystallinity and not
the presence of the amorphous state [18,19]. Some of the amorphous drug
systems classified as amorphous may exists as a liquid crystals because of
inadequate physical characterisation [20].
Several methods for the preparation of amorphous forms of drugs and
chemicals have been described in the literature (Table 1). At the moment, the
most common methods for large-scale production of amorphous material are
freeze-drying, spray-drying and melt extrusion [19]. At the beginning of the
new millennium it was approximated that about 8 of the 60 new chemical
and biological entity solid dosage forms approved by the FDA were partially
or completely amorphous and were prepared by freeze-drying [21]. One
reason for the popularity of freeze-drying in production of amorphous
materials is that the operation parameters can be easily controlled and
measured. In addition, many pharmaceutical companies have the necessary
instruments, and amorphous matrix has been observed to increase the
chemical stability of proteins and peptides.
Usually, excipients are needed to stabilise and to improve processability of
amorphous drug formulations. Quite a common method is to use a solid
dispersion where the API is formulated into a matrix or a carrier [22].
Unfortunately, these formulations are often sticky and they need a great deal
of excipients [14,23]. Extrusion methods are especially used to formulate solid
dispersions, because chemical degradation can be reduced by controllable
energy input during processing [19].
Phase changes during storage or processing may also change material to
an amorphous form. Hydrated sodium celecoxib was found to transform from
the crystalline hydrate form to an amorphous form during storage, which
increased oral bioavailability [24]. Dehydration might be a quite useful
method to produce amorphous material because it does not cause high
physical stress on the material processed, as occurs in milling and melting
methods. However, the utility of the dehydration method depends on the
hydrate form of the drug because not all hydrates can form a pure
amorphous material when dehydrated.
-Literature review-
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Table 1. Methods to prepare amorphous materials.
Method Processing
temperature
Industrial scale [°C]/ s, l * Possible problems in processing method Reference
Freeze-drying < 0 °C / s Many processing steps
Consumes energy
Slow and thus expensive
Limited capacity
Residual solvents
[3,25]
Spray-drying
Spray-freezing
> 25 °C / l
< 0 °C / l
High temperature (spray-drying)
Many process parameters
Energy consumption
Residual solvents
[26-28]
Melt extrusion > 25 °C / s, l High temperature
High amount of excipients/water are
usually needed
[29]
Other methods [°C]/ s, l * Possible problems in processing method Reference
Addition of
impurities/isomers
approx. 25 °C / l Not well studied at least with isomers [30,31]
Melt quenching > 25 °C / s High temperature
Cooling is usually needed
Chemical degradation
Energy consumption
[18,19,21,32,
33]
Precipitation by
antisolvent
addition
approx. 25 °C / l Rapid addition of solvent
Residual solvents
Solubility problems if water is used
[33]
Dehydration of
hydrated crystals
> 25 °C / s Promising method
Not suitable for all crystals
[34]
Mechanical stress
(milling, grinding)
< 25 °C / s Milling time dependence
High temperature if cooling is not used
Dependent on crystal structure
Seed crystals remain in formulation
[35]
High pressure
compaction
approx. 25 °C / s Pressure from 0.1 to 5 GPa
Energy consumption,
Only suitable for small amounts of material
[36]
Electric field approx. 25 °C / s Not used for drugs
Only tested for polymers
[37]
pH change approx .25 °C / l Residual solvents [33]
Vapor deposition > 25 °C / s New method for drugs
Materials prepared have extraordinary
properties like physical stability
Chemical degradation
[38]
Vacuum systems > 25 °C / l Residual solvents [39,40]
Electrospinning > 25 °C / l, s Amorphous drug-polymer nanotubes
Not a large scale production method
[41]
Ultrasound approx. 25 °C/s, l Cavitation
Chemical degradation
Not tested for drugs
[42,43]
* Starting material at the beginning of the process, s, solid and l, liquid.
-Literature review-
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Processing method has an effect on the physical and chemical stability of
the amorphous state. Patterson and co-authors (2005) compared ball milling
and quench cooling of four different pharmaceutical drugs: dipyridamole,
carbamazepine, glibenclamide and indomethacin [35]. Quench cooling was
observed to be a more effective method to prepare physically stable
amorphous form than ball milling, but it may induce chemical degradation.
Production of an amorphous form by ball milling is dependent on the unit
cell structure of the crystalline drug. Vacuum/film drying was found to
produce physically more stable amorphous material than freeze-drying or
spray-drying [40]. Stability properties differ across drug substances because of
changes in the physical properties of drugs. In addition, processing
parameters such as the spraying temperature (inlet-outlet temperature) in
spray-drying have been found to have an effect on the physical stability of
amorphous form although the glass transition and infrared spectra of
materials were similar [44].  This result was related to the degree of disorder
in the amorphous materials, which depended upon the processing
temperature. According to Shalaev and Zografi (2002), changes in processing
parameters produce different kinetic states for amorphous materials [45],
which may have effect on physical/chemical stability.
2.2 Properties of the amorphous state
2.2.1 Glass transition
The glass transition temperature (Tg) is the most important parameter of an
amorphous material [46]. The nature of a glass and Tg is considered to be the
most interesting unsolved problems within solid state science [47]. There are
many theories for glass transition, but they are reviewed elsewhere (in e.g.
[1]). Glass transition is observed when an amorphous solid (glass) changes
into a supercooled liquid state during heating or to the reverse during
sample cooling (Figs. 1 and 2).
A schematic representation of the difference between the glass transition
(Tg) of an amorphous material and melting (Tm) of a crystalline material is
shown in Fig. 1. Tg is thought to be approximately 2/3 of the melting
temperature [48]. In principle, all fluids or melts can be turned into
amorphous glass if the cooling rate is rapid enough and the material does
not crystallise during cooling [49]. Glass transition is a kinetically controlled
phenomenon and thus different cooling rates have effect on Tg (Fig. 1) [50].
Upon cooling melt can enter a supercooled liquid state if the melt does not
crystallise at temperatures below melting point. During cooling the viscosity
increases and the material starts to solidify forming a glass at temperature
below  Tg. Upon cooling there is also observed change in thermodynamic
properties such as volume, enthalpy and entropy (Fig. 1). The Kauzmann
-Literature review-
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temperature (Tk) is a hypothetical temperature where the molecular
rearrangement approaches a minimum value i.e. equal to that of the crystal
[48]. It can be extrapolated from the thermodynamic properties such as
volume, enthalpy or entropy.
Glass transition involves changes in molecular motion. The structural
relaxation time (?) is used to evaluate molecular mobility in the amorphous
state. At Tg, ? is about 100 s, and much less at temperatures above Tg [51].
Molecular motions are restricted in a glassy state to vibrations, stretching and
short-range rotational motions.
Glass transition is associated as ? relaxation, where molecules may have
translational motions. At temperatures below Tg, there are also other
relaxations called ?, ?, … relaxations, with decreasing transition
temperatures. The magnitudes of those other ?, ? relaxations are much
smaller than ? relaxation. The origin of ? and ? relaxations are still unclear for
small molecules, but in large molecules such as polymers it has been stated
that these relaxations are local mode relaxations in the polymer chain and
the rotations of terminal groups and side chains [46]. Above Tg, molecules
may have translational movement. These higher molecular motions are
restricted to small regions (15%, V/V) surrounded by less mobile fractions
[52]. It has also been proposed that molecules move a distance of 20% of the
molecular diameter at temperatures near the Tg [53].
V
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Crystal
                Liquid
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 liquid
Figure 1 A schematic representation of changes in entropy, enthalpy and volume
as a function of temperature for a material that can be in the crystalline
or amorphous state. Glass 1 is cooled down more rapidly than Glass 2.
Kauzmann temperature (Tk); glass transition temperature (Tg); melting
temperature (Tm) of the crystalline material. Modified from Ediger and
co-authors (1996) [51].
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Physical changes in the glass transition can be studied using different
instrumental methods [32,54-56] (Fig. 2). The material is sticky and more
elastic at temperatures above the Tg than at lower temperatures. Stickiness
decrease the processability of the material and there can be some problems
in storage of amorphous pharmaceuticals. An increase in molecular mobility
and reduction in the viscosity of an amorphous material has time-dependent
structural changes in material properties such as crystallisation, stickiness and
collapse of material structure [1,56,57]. In addition, increased diffusion, rates
of enzymatic reactions, the Maillard reaction and oxidation are related to the
glass transition [58]. Reaction rates are dependent on the temperature
difference Tambient-Tg.
?
      T
g
Temperature
Liquid
Glass
      T
g
Temperature
   
   
   
 C
p
,?
???
             Liquid
Glass
Tg
Temperature
??
              Glass
????????Pa?s
                             Liquid
(A)     (B)
  (C)
Figure 2 Changes in physical properties during the glass-liquid transition (Tg). (A)
Coefficient of expansion (?), isobaric expansivity (?), isobaric heat
capacity (Cp),   (B) viscosity (?), and (C) dielectric constant. Modified from
White and Cakebread (1966) [56].
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2.2.2 Physical aging
Physical aging is a structural relaxation towards thermodynamic equilibrium
as a function of time [59]. Annealing and physical aging are often used as
synonyms in the literature. Physical aging is observed at temperatures below
Tg in the non-equilibrium state, and it occurs at a constant temperature at
zero stress without any external input. A schematic presentation of the
physical aging of glass A to glass B during annealing time (t1) is presented in
Fig. 3. At low temperatures, new apparent equilibrium is difficult to achieve
because molecular mobility is low and thus the time scale for observing
physical aging is long [59]. Different apparent equilibria exist below Tg
depending on thermal history and processing of the amorphous material. At
temperatures above Tg, physical aging is not observed because molecular
mobility and thus molecular rearrangement occurs so quickly that equilibrium
is achieved rapidly.
A thermodynamic driving force drives an amorphous material towards the
crystalline state during annealing. Another reason for physical aging is
molecular motion that still happens at a lower temperature than Tg but over
a longer time than in the liquid state. The molecular relaxation time (?)
increases as the glass relaxation progresses [60]. Thus, physical aging
experiments will take time.
 Reversible changes in enthalpy, specific volume, mechanical, spectroscopic
and dielectric properties can be used for the detection of physical aging. The
most widely used method is DSC, where an endotherm is recorded at or near
Tg due to physical aging.
In materials science, it has been found that more compact molecular order
and strengthened molecular interactions change the physical properties of
the amorphous material, such as mechanical and diffusional properties due to
annealing [61]. Physical aging decreases water vapour sorption in amorphous
systems [62]. Thus, sorption properties are dependent on time, because
structural transformations and phase transitions may have an effect on
sorption [1].  Physical aging is observed to have an effect on the density,
brittleness, and compaction properties of polymer materials [63-67]. Hence,
annealing has gained considerable attention during the past few years. In
addition, amorphous materials often crystallise during aging [68]. Physical
aging also increases ultrasound attenuation in polymers and thus physical
aging has an effect on ultrasound processing [69].
Controlled annealing has been observed to increase the chemical stability
of amorphous systems compared with non-annealed materials [70]. This
might be related to lower molecular mobility in the annealed material. Pfizer
has patented a method in which annealing is used to improve the chemical
stability of amorphous materials by different annealing methods such as
temperature, pressure, microwaves and ultrasound [71,72]. Annealing was
found to decrease the degradation rate of amorphous material in longterm
storage [72]. Because different processing conditions, parameters and
-Literature review-
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equipment produce glasses of different kinds, controlled annealing might be
one solution to solve problems with interbatch variation.
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Figure 3 A schematic representation of physical aging of glass A to glass B during
aging time (t1) at annealing temperature (Ta). Fictive temperature (Tf) is
the temperature where the structure of the glass (Tf  A or  Tf  B) is fully
relaxed. Crystals are stable against annealing. Modified from Hancock
and others (1995) [73].
2.3 Factors affecting physical stability of the amorphous
state
The physical stability of amorphous material against crystallisation is
reviewed. The dissolution rate of a drug decreases when the material is
transformed from the amorphous state to the crystalline state. Thus, the
pharmaceutical industry and many researchers are studying different
methods to stabilise amorphous drugs. Today, there are two different views
in the literature concerning what are the main factors for physical
stabilisation of the amorphous state. They are: (1) interactions between
molecules or (2) molecular mobility. However, molecular interactions and
molecular mobility are usually interrelated. In addition to these two, there
are many other factors considered to be important, and thus these different
factors are reviewed, some of them are also related to molecular interactions
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and molecular mobility. Inhibition of crystallisation is being affected by more
than one factor [74].
2.3.1 Molecular interactions
According to Ovshinsky (1985), the first rule of non-crystalline solids is that
atoms have bonding options, and the second rule is steric hindrance [75].
Steric hindrance prevents molecules from making contact with each other
and thus the desired atomic and molecular arrangements for forming a
crystal lattice. Such obstacles to molecular motion can be crosslinks and
bridges, which prevent crystallisation.
Hydrogen bonding plays a crucial role in the stabilization of organic
structures [76]. Similarly, the crystallisation tendency of drugs has been
explained by differences in hydrogen bonding, steric structure and symmetry
[77]. Having many possibilities for forming hydrogen bonds between
different acceptors and donors makes the crystallisation of molecules more
difficult [4,78] due to possible mismatches in hydrogen bonds.
An interaction model explains formation of a non-crystalline state by the
disruption of specific drug-drug interactions or by the formation of specific
drug-excipient interactions. In network glasses, crystallisation is prevented by
directional bonds that inhibit the formation of long range order [79] and it
has been proposed that, in the sugar glasses, hydrogen bonds act as a
network [80]. However, there are studies which have reported that hydrogen
bonding is not needed to stabilise an amorphous drug [81].
There might also be some cooperative interactions in amorphous
materials. Hydrogen bonding is reported to decrease polymer chain
mobilisation and thus has an effect on measured Tg. Tg  of a thin polymer film
was found to decrease with decreasing film thickness on a gold surface [82].
This was explained by the decreased cooperativity of molecules in the thin
film and lack of interactions between the gold and polymer layer. The Tg of a
film increased with decreasing film thickness on silicon oxide, and it was
postulated that weak hydrogen bonding to silicon might have increased the
Tg. Similarly, for amorphous drugs, such as indomethacin and celecoxib,
milled materials crystallised more easily than unmilled materials [83,84]. It is
more likely that the milling processing of these drugs triggered crystallisation
than the decreased cooperativity between molecules. Furthermore, the
crystallisation of small glass forming molecules is found to start at interfaces
[85].
Specific understanding of interactions between excipients and
proteins/peptides/drugs is a key factor for further development of
pharmaceutical processes such as freeze-drying because these interactions
may vary from protein to protein [86] and thus a clear rule of thumb for
physical stabilisation of amorphous forms has not been developed yet.
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2.3.2 Molecular mobility
Molecular mobility has been found to be related to the chemical and physical
stability of drugs [73,87,88] and even to microbial responses in foods [89].
Molecular mobility is thought to predict the shelf life of an amorphous
pharmaceutical product. The practical storage temperature of an amorphous
material is proposed to be 50 °C lower than the Tg, because molecular
mobility is assumed to be so low at these temperatures that it has a minor
effect on physical stability [73]. This temperature is quite near the Tk
(Kauzmann temperature) where molecular mobility vanishes. However,
crystallisation is reported to occur at 175 °C below the Tg [90], although the
maximum crystallisation rate is reported to occur between Tg and Tm [54,91].
At temperatures below Tg, molecular motion is too slow for crystallisation. At
temperatures higher than the Tm, thermodynamic equilibrium is shifted to the
liquid state preventing crystallisation. Crystallisation is dependent not only on
temperature but also on aging time [92].
The structural relaxation time (?) is used to estimate molecular mobility in
amorphous materials. Nowadays, the methods for measurement of ? are
mainly thermal methods, for example DSC, or more often solid-state NMR
(ssNMR). The relaxation time is frequently correlated with the shelf life of the
amorphous product and thus molecular mobility is studied widely. However,
there are still many theoretical and practical limitations to the use of
molecular mobility concepts to predict the chemical and physical stability of
an amorphous material, such as accuracy of measurements [93]. There is also
need to develop theories to explain role of molecular mobility on physical
stability.
In the literature, there are many methods to describe molecular relaxation
times  (?). The Kohlrausch-Williams-Watts (KWW) equation (Eq. 1) is widely
used to define the mean relaxation time distribution constant (?)  and mean
molecular relaxation time constant (?kww) using the extent of relaxation (? ). In
enthalpy recovery experiments using DSC [73], an amorphous material is
stored for different times (t) at a temperature (TA)  below the Tg to observe
enthalpy recovery (?H) in the DSC scan. Maximum enthalpy recovery (?H?) is
calculated using Equation 2 (Eq. 2) where the measured heat capacity change
(?Cp) at Tg is used.
(1)
?
?
?
?
?
?
?
?
?
?
??
?
??????
?
???
?
?
???
?
?
?? kww
t
H
H exp1
(2) pAg C)T-(T ??? ?H
The Adam-Gibbs-Vogel (AGV) theory describes glass relaxation controlled
by configurational entropy and activation energy [94] and it is often
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presented as in Equation 3 (Eq. 3) [95]. Because the KWW equation only
describes the average for ?, a method for calculating the time-dependence of
molecular mobility has been described [60]. The fictive temperature (Tf) is
calculated as in Equation 4 (Eq. 4) which is combined with the normal AGV
function (Eq. 3). A parameter ? is related to the ratio of Cp of the crystalline
and glassy materials at Tg. The superscripts of Cp are liquid (l), glass (g) and
crystal (c). The initial relaxation time (?0) of newly prepared glass can be
calculated as shown in Equation 5 (Eq. 5) [93].
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The Vogel-Tamman-Fulcher (VTF) equation (Eq. 6) describes non-Arrhenius
temperature dependence of the relaxation of a glass forming liquid i.e. a
supercooled liquid. The temperature T0 corresponds to the ideal glass
transition temperature where relaxation times approach infinity and it is
typically quite near the Tk. The "parameter of strength" (D), indicates
deviation from Arrhenius’ law and it describes the fragility of the liquid. For
fragile liquids, D would be below 10 and 30 to infinity for very strong liquids
[96-98]. ?0 is the pre-exponential factor, being usually of a similar order of
magnitude as vibrational lifetimes (i.e. 10-14 s). Fragility (D and T0) parameters
can be determined using the Vogel-Tamman-Fulcher (VTF) equation from the
viscosity data, because viscosity (?) is related to molecular relaxation time (?).
Crowley and Zografi (2001) have described how to evaluate fragility
parameters using thermal methods [97].
(6) 0
0
0
TT
DT
e ????
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2.3.3 Other factors affecting physical stability
Development of blends with high Tg, which is related to molecular mobility, is
one of the most commonly used methods for increasing the physical stability
of amorphous materials. Quite often polymers are used to increase Tg [99]
due to their antiplasticising capability. However, it seems that the
effectiveness of the additive for preventing crystallisation is not directly
linked to the change in Tg [100]. Mixing amorphous drugs with a polymer has
also been found to decrease the free volume of the system [101] and thus
increase the physical stability. Other factors favouring the formation of the
glassy state are: a high viscosity in the liquid just above the solidification
point, a rapid rate of cooling, a complex molecular structure and the
presence of more than one molecular species in the system [56,102].
Purification during large-scale manufacturing of a new amorphous API may
produce problems. The first batch produced at the beginning of the
development of a new API contains more impurities than production scale
batches. Thus a metastable form may crystallise in the production scale
batches due to lowered impurity level [31]. Isomers of drugs/excipients can
also be used to stabilise the amorphous state as in, for example, mannitol-
sorbitol binary mixtures [30].
In biological materials addition of some other components such as salts
[103] and surfactants [104] stabilise chemically amorphous systems during
freeze-drying. The mechanism of stabilization is still unclear. Complex
formation between salts and sugars is thought to be one reason for the
increased chemical stabilisation [105,106]. Ranbaxy laboratories has patented
a method where less than 5% (w/w) of alkali metal salts has been added into
amorphous atorvastatin formulation and it has been observed to increase the
chemical stability of the drug [107]. Surfactants are assumed to change the
interface between different phases [104]. These factors may also have an
influence on physical stability of freeze-dried systems.
The benzene ring is believed to act as a steric hindrance in m-toluidine
glass that restricts the hydrogen bond network from growing in a single
direction [108]. Aromatic rings and rings with other electron donating groups
are thought to stabilize intermolecular interactions such as dipole forces in
the amorphous state [109].
Large and heavy halogen atoms are found to disturb molecular crystal
packing and diffusion of molecules in the crystallisation process, favouring
glass formation [110]. Crystallisation tendency of halogenated compounds
increased in the following order: F<<Cl<Br. Similarly, Tg decreased in the
following order Br > Cl > F (Tg from 54 °C to 72 °C) and Tm decreased in the
following order F > Cl > Br. The bulkier and heavier halogen substituents
were thought to disturb diffusion and packing of molecules. In drug
molecules, the form of a salt has been observed to change the Tg of
indomethacin (free indomethacin Tg 42 °C) from 69 °C to 139 °C due to
changes in electrostatic interactions between the carboxylic acid and the
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alkali salt [111]. This is an interesting finding because pharmaceutical drugs
often have halogen substituents or different salt forms.
Hydrogen ion activity (pH) is known to be important in the liquid state for
the chemical stability and properties of a molecule. However, in the solid
state the effect of hydrogen ion activity is still unclear [3]. Solid-state pH has
been postulated to have an effect on the chemical and physical stability of an
amorphous system [112,113] and it has also an effect on preparation of
amorphous or crystalline drug from the solution [114]. Still, there is a
problem of how to measure solid-state pH in a reliable way. The
devitrification kinetics of amorphous irbesartan (weak acid, pKa is
approximately 4.9) have been observed to be slower in acidic conditions than
in pure water [115]. Thus, it might be that the drug release site in the human
body (pH) might have an effect on the bioavailability of an amorphous drug,
although the apparent dissolution rate of an amorphous drug should be
good.
An amorphous system is thermodynamically in a non-equilibrium state and
thus it tries to achieve an energetically more stable crystal form.
Thermodynamic properties are believed to be the driving force for the
crystallisation of amorphous material [116-118] and they are thought to be
more dominant mechanisms in crystallisation of amorphous material than
molecular mobility [117]. Such thermodynamic properties as configurational
entropy [118], differences in free energy (enthalpy and entropy) [117] and
the kinetic barrier for crystallisation [116] are considered to be important for
approximating the crystallisation tendency of drugs.
In the solid dispersions, physical stability is related to the crystallisation
tendency of the pure amorphous drug [119]. Thus, drug properties also have
an effect on the physical stability of dispersions. The amorphous state has
been found to be physically more stable within drugs with a complex
molecular structure. The conformational flexibility of molecules allows
development of more stable amorphous drugs and thus the number of
amorphous drugs on the market has increased [4,78,102,120]. Low structural
symmetry and a bulkier structure are also known to be important inhibitors
of crystallisation [121].
2.4 Stickiness
A material appears sticky when it has a tendency to adhere to a contact
surface. The stickiness of amorphous materials causes problems in processing
which can be operational problems, material losses, agglomeration and
clumping [122,123]. Sticking to fingers and packaging increase also
customers’ dissatisfaction [123].
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2.4.1 Theories of adhesion
Adhesion happens between two different surfaces. Cohesion is formed
between two similar surfaces. Both phenomena are a result of forces
between molecules [124]. Present theories are not describing in detail all the
interactions that occur during adhesion and what the primary forces involved
are. The forces operating in adhesion and cohesion are van der Waals forces
(physical adsorption), hydrogen bonding (strong polar attraction), ionic,
covalent or chemisorption forces. Van der Waals and electrostatic forces are
primary factors for adhesion whereas chemisorption or covalent bonding
much less commonly play a role [125].
The theory of adsorption assumes that adhesion is the result of molecular
contact between two materials, causing surface forces to develope. A good
contact requires that the separation of surfaces should be less than five
Ångströms, which means good wetting between the surfaces. There should
not be air pockets along the interface and the wetting should be complete.
Thus, when good wetting is desired, the surface energy of the surface (?s)
must be high and the surface tension of the wetting liquid (?l) must be low
i.e. ?s >> ?l [124].
In the mechanical theory of the adhesion, the adhesive has to penetrate
the cavities of the substrate [124]. Increasing the surface roughness assists
mechanical anchoring because it may increase interlocking, the formation of
a clean and reactive surface or surface area. The mechanical theory also
explains the main adhesion mechanism for a porous material. It requires that
the adhesive displaces trapped air to get good contact. There may also be
liquid bridges between surfaces [126]. Electrostatic forces are important for
adhesion between electrical double layers. This concept is widely used in
biological cell adhesion [124]. The diffusion mechanism is possible for large
molecules like polymers, for instance. It requires that polymer molecules are
capable of moving. Polymers are diffused between each other and this
induces entanglement and thus adhesion [124].
 In the weak boundary layer mechanism, in order to get a good contact
between adherend and surface other weak boundary layers such as air and
water must be removed. This means that when adhesion fails, it is the result
of failure of a weak boundary layer, not a failure of an adhesive surface.
Thus, adhesion is the result of the combination of environment, adhesive and
surface. Again, surface treatment is important in order to remove any weak-
boundary layer.
The suction cup theory was created because van der Waals forces are a
ten-thousandth of the force exerted by an adhesive tape [127]. The suction
cup theory is related to air bubbles on rough surfaces that lead to a suction
effect when attemting to remove the adhesive [128]. This suction effect keeps
the adhesive stuck to the surface.
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2.4.2 Factors causing stickiness
Several factors have been implicated in stickiness (Table 2). Factors increasing
stickiness are hygroscopicity, solubility, low melting point, viscosity,
temperature, mechanical stress, excipients and particle size [123,129,130]. In
addition, long contact time increases caking and stickiness even if all the
other factors are the same [131]. When the viscosity of an amorphous
material decreases rapidly, it causes stickiness. The critical viscosity incurring
stickiness and caking was found to be approximately 107 Pa·s [132]. Viscosity
can be related to relaxation times above the glass transition temperature
[46].
Table 2. Factors causing stickiness and their relative contribution. Negligible
contribution (0), high contribution (+), higher contribution (++), the
highest contribution (+++). Modified from Adhikari and co-authors
(2001) [123].
Factors Relative contribution
to stickiness
Reference
Protein 0 [123]
Polysaccahrides 0 [123]
Fats + [123]
Particle size distribution + [123,125]
Low molecular weight sugars ++ [123]
Organic acids ++ [123]
Compression/ pressure ++ [123]
Water/ relative humidity +++ [123,133]
Temperature +++ [123]
Viscosity +++ [123]
Some other factors Relative contribution
to stickiness
Reference
Glass transition temperature +++ [124,134]
Solubility +++ [124]
Surface free energy +++ [124,132]
Contact time +++ [132]
The chemical properties of a material, such as polarity and surface
properties i.e. the surface energy, have an effect on wetting. The important
factor for adhesion is that the adhesive should be able to flow on a molecular
level to grip surfaces [124]. In two-phase systems, solubility parameters
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between components are important because the difference in solubility may
disturb bonding due to phase separation.
 An increase in temperature over the Tg increases the molecular mobility
and therefore the material can deform more easily under stress. In addition,
the number of contacts between molecules increases as the molecular
mobility increases and thus the adhesion is more elastic. A high molecular
weight usually increases cohesion but decreases adhesion. High temperature
and humidity favour caking of soluble materials especially if the melting
point of the material is low. Crystallinity, molecular weight and polymer
crosslinking decrease molecular mobility and thus decrease the adhesion
bond strength against stress, while increasing cohesion [124]. In addition, an
extended contact time increases caking and stickiness, even if all other factors
are the same [57].
In Figure 4, the effect of temperature on stickiness as a function of water
content is shown. A sticky region has an upper and lower limit depending on
the viscosity. The temperature or water content will plasticize the amorphous
material, inducing stickiness. At temperatures above Tg, material is changed
from a glassy to a supercooled liquid state, which may cause stickiness [54,57].
The sticky point of amorphous sugars is from 10 to 20 oC higher than the glass
transition temperature [57,134]. Viscosity in this temperature range changes
from 106 to  108 Pa·s [132]. The sticky-point of skim milk is from 4 to 23 °C
higher than the Tg [135]. If the product temperature is lower than the Tg,
stickiness and adhesion will not take place [57].
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Figure 4 Effect of temperature, water content, viscosity and glass transition
temperature on the sticky region. Modified from Roos (1995) [1].
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2.5 Processing amorphous or sticky material into a solid
dosage form
Powder stickiness is a problem when material with a low Tg is processed into a
solid dosage form. Stickiness induces problems in processing of solid dosage
forms if nothing else because authority requirements are high in the
European Pharmacopoiea for Uniformity of Dosage Units (European
Pharmacopoeia 6.0, 2.9.40) and stickiness interferes with uniformity.
Lowering of temperature and water content are the first methods in the
prevention of caking and stickiness of amorphous material [61]. In addition,
many other formulations, such as solid dispersions, have processing problems
because they are usually sticky and hygroscopic [23]. To prepare a solid
dosage form from sticky material is possible but it requires huge amount of
excipients. Preparation of a 25 mg indomethacin solid dispersion tablet
requires approximately 600 mg excipients, for instance [14]. In this literature
survey, some possible processing methods for sticky material are introduced.
However, many processing methods may cause crystallisation of  amorphous
material during processing [136].
2.5.1 Temperature and water content
Low temperature and water content increase the viscosity of amorphous
material and thus decrease stickiness during processing (Fig. 4). Another
technique to process the material at high temperature, where amorphous
material behaves like a liquid, and use it to fill capsules, for instance [137].
This processing technique might have some drawbacks because some
amorphous material might start to degrade or crystallise at the temperatures
needed to decrease viscosity. Thus, low temperature processing is an
important method in the processing of sticky material.
In low temperature processing, it is important to control the temperature
of the wall in contact with the material. One way is to use cold air or some
other cooling system in the bottom of the processing chamber [123]. In
addition, mechanical scrappers are used to decrease the mass stickiness on
the walls. One problem with cold air is the condensation of water on the
chamber wall if the processing is done in ambient conditions. The problem of
water condensation can be solved by using free flowing nitrogen gas in the
chamber or some other inert gas. For cryogenic processing (i.e. the use of dry
ice, liquid carbon dioxide or liquid nitrogen) the problems are high operation
costs and high energy consumption [138]. The cost of liquid nitrogen is
approximately 43% of the total costs of the industrial scale system [139].
After cryogenic processing, further processing of a solid dosage form requires
low temperature facilities/rooms to inhibit stickiness. Thus, some other
techniques are more realistic and cheaper to use for industry than cryogenic
processing.
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2.5.2 Antiplasticizer
Amorphous material can be plasticized thermally and using plasticizers.
Plasticizer is usually a liquid e.g. water or other small molecular weight
molecule acting as a lubricant in the blend. Thus, antiplasticizers are used to
increase Tg or absorb/adsorb water. Water drastically decreases the Tg of
amorphous material and only a small amount of water may cause a
significant decrease [54]. One type of antiplasticizer used is a porous
antiplasticizer which competes for available water [140]. This is due to the
fact that excipients will protect an amorphous drug from moisture [141,142].
Good water sorption of residual water by the amorphous excipient might be
one reason why amorphous excipient is a good chemical stabilizer for protein
formulation in freeze drying [143]. Usually in amorphous drug formulations
microcrystalline cellulose, starch, sugars and silicone dioxide are used as water
sorbents.
Some other antiplasticizers (e.g. silicone dioxide) interfere with liquid
bridging, decrease friction, reduce molecular attractive forces and inhibit
crystal growth [140]. High molecular weight sugars and starch derivatives are
used to increase Tg and thus can be successful in decreasing stickiness in food
products [144]. Maltodextrins have been used to aid drying, thereby
minimising stickiness and caking during spray-drying because they increase Tg.
Common sugars such as fructose and sucrose have low Tg’s [131]. The effect of
ingredients on Tg is predicted by the Gordon-Taylor, Couchman-Karasz or
Huang equations in multiple systems [1]. It might be that Tg is not the only
factor responsible for stickiness, because the surface properties of dried
materials, such as porosity are also important. Lipids may reduce caking by
forming a water-protective barrier [130].
2.5.3 Drying methods
Nowadays glassy pharmaceutical products are processed mainly by drying
(Fig. 5, Table 1). Sublimation is used in a freeze-drying process where the
solution of excipients and an active pharmaceutical ingredient (API) is dried
under suitable conditions. The freeze-drying process is slow in comparison
with spray-drying and it also requires high amounts of energy. In spray-drying
and chilling the solution is sprayed into a warm or cooled chamber,
respectively. Spray-drying is more common due to simultaneous drying in the
chamber, whereas chilling needs a separate drying step after spraying, if
solvent is used. These processes produce amorphous form due to rapid liquid
evaporation or solidification. Spraying can be difficult due to stickiness and it
requires a substantial amount of drying aids, which increase the size of the
solid dosage form [145]. Sometimes processed material might still be sticky
after drying and thus difficult to process further into solid dosage form.
-Literature review-
21
Vacuum drying (l)Freeze drying (l)
Spray chilling (l, melt)
Adsorption in porous
material (l, melt)
Microcapsules, microparticles (l)
Melt extrusion (l, s)
Cryogrinding/
cryoprocessing (s, l)
25 °C
Processing temperature
Spray drying (l)
C
on
ce
nt
ra
tio
n 
of
 st
ic
ky
 m
at
er
ia
l
Figure 5 Different ways of processing sticky substance into a solid dosage form.
Concentration of sticky material in the beginning of the process as a
function of processing temperature. Concentration will change
depending on the physical form of the sticky material,  l, is liquid,and s, is
solid, or melt.
2.5.4 Dispersions
There has been active research within the solid dispersion field but usually
there are problems with scale-up and chemical or physical stability, explaining
why there are only a few solid dispersions on the market today  [14,146].
Solid dispersions can be used for processing of sticky substance and they can
be further processed into different solid dosage forms such as soft/hard
capsules, tablets and granules depending on the excipients.
Karrlsson and co-authors formulated greasy/oily/sticky substances into
solid polymeric matrices [147]. The amount of drug in the beads varied from
15% to 70% (w/w). Chiesi and Pavesi (1991) mixed oil/ triglycerides or soya
lecithin with ipriflavone to produce a dispersion [148]. The dispersions were
enclosed in soft gelatin capsules. The amount of ipriflavone in capsules was
50% (w/w) of the total mass. Yanai and colleagues (1997) made a dispersion
of API in an oleaginous base [149]. The dispersion was a liquid or a solid
depending on the quality of the oleaginous base. The amount of API varied
from 25% to 50% (w/w) in solid- or liquid dispersion, respectively. A similar
method has been used in dosing of HIV protease inhibitors [17]. The size of
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the dosage form was huge because 200 mg of API needed approximately 800
mg of glycerides. The large size makes these formulations difficult to
swallow. In various lipid-based vehicle formulations, maximum drug loading
varies from approximately 30% to 40% (w/w) [150].
2.5.5 Melt extrusion
Because the melt extrusion process cannot be used for a pure drug substance,
it is quite often used to prepare solid dispersions having carriers in the
formulation. Melt extruded materials can be used to make capsules and
tablets. Breitenbach and his colleagues (1995) used water soluble PVP and
starch derivatives in the melt extrusion of drugs, vitamins and amino acids
[151]. The maximum amount of model substance could be 60% (w/w)
depending on the drug properties. The processing temperatures of extruders
usually range from 60 °C to 150 °C. High temperatures may increase
degradation of the API during processing. The melt extrusion method has
also been used for liquids (melts and solutions) where the maximum liquid
load was approximately 40% (w/w) [152].
2.5.6 Loading into a porous structure
Loading into/onto a porous structure is a common method for processing oily
and sticky substance. Quite often oil and oil soluble substances are loaded
into natural polymers, such as materials derived from starch, dextrin or gum,
by spray-drying. In an adsorption test, agglomeration of adsorbent started
when 41% (w/w) of light mineral oil was added [153]. Total sorption (i.e.
glimmering of the surface) of light mineral oil on a natural polymer was
334.9% (w/w). Natural polymers are observed to be good
adsorbents/absorbents because they usually adsorb/absorb more material/oil
into/onto themselves than magnesium carbonate does, for instance.
Furthermore, adsorption of emulsions onto silica particles is possible [154].
Adsorbed/absorbed particles can be further processed with different drying
methods, as described by Breton and co-authors (freeze-drying/spray-drying)
[154]. Again, the size of this preparation might be too big if a relatively high
amount of API is needed in a single dosage form.
2.5.7 Microcapsules and microparticles
Microcapsules and particles can be processed into a solid dosage form.
Microcapsulation is a rather slow and complicated process. Perrier and
Buffevant (1993) introduced polysaccharide microcapsules and microspheres
for food, cosmetic and pharmaceutical ingredients [155] but also some other
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materials can be used to form microparticles. It was possible to capsulate oily,
liposoluble, water soluble and non-soluble particles. The drug loading in
these microcapsules was approximately 40% (w/w) (o/w emulsion). Calcium
gluconate for the preparation of fatty acid microparticles has also been used
where the mixture of ingredients is dried and pulverized [156]. The amount
of calcium gluconate was preferably from 50% to 90% (w/w) in these
microparticles. Kumabe patented in 1999 a method for encapsulating oily, oil
soluble and water soluble substances in a calcium microparticles [157].
2.6 Ultrasound processing
2.6.1 Principles
The definition of ultrasound is a pressure wave oscillating at a frequency
above human hearing, i.e. above approximately 20 kHz (Fig. 6). Ultrasound
processing is done without high forces and large displacements [158]. An
ultrasonic apparatus consists of an electromechanical transducer, which
usually is made of the piezoelectric ceramic of lead zirconate titanate due to
its electromechanical conversion efficiency.  Typically, conversion efficiency is
95% or more [158]. It is a non-contact method and it can be sealed outside
the operation vessel. Thus, ultrasound can also be used in instrumentation
where frequencies vary from 20 kHz in gases to 10 MHz in solids [159].
Intensities used in ultrasonic cleaning baths are approx. 1 W/cm2, and in
laboratory scale sonochemistry, intensities varies from 50 to 500 W/cm2 [42].
Power levels in low intensity ultrasound are less than 1 W/cm2 and  thus  no
physical or chemical reactions in materials are detected [160]. Ultrasound
cannot travel in a vacuum because it is a pressure wave. Effects on materials
are cavitation and microstreaming in liquids. Cavitation occurs when
microbubbles in the liquid rapidly collapse inducing a shock wave. In
sonochemistry, ultrasound is used as a processing aid to accelerate chemical
reactions. Ultrasound produces high local temperatures, pressures and rapid
temperature changes and thus it is widely used in materials chemistry [42].
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Frequency (Hz) 0 10 102 103 104 105 106 107
Human hearing 16 Hz - 18 kHz
Power US*
Sonochemistry 20 kHz - 2 MHz
Diagnostic US*
Figure 6 Frequency (Hz) ranges of sound. *US, ultrasound. Modified from Mason
(1999) [161].
2.6.2 Possibilities for ultrasound processing
Ultrasound offers versatile possibilities as a processing aid for different kinds
of industries [162]. From the pharmaceutical point of view, the most
interesting processing applications are the fluidisation of powders and
granular materials, decrease of friction between particles and die walls,
handling of living cells, crystallisation, impact grinding, extrusion and
diffusion, agglomeration in suspensions, the treatment of fibers, cleaning
and homogenisation. Thus far, ultrasound has been used in pharmaceutical
technological processes such as crystallisation [43], tableting [163],
granulation [164], diagnostics and cleaning.
The six most frequent applications of ultrasound are cleaning, plastic or
metal welding, extraction, homogenising, atomisation and machining [158].
Plastic remains solid in ultrasonic cold forming/welding, probably due to the
reduced internal friction [162]. Ultrasound is widely used in food processing
to increase mass transfer in gas-solid and liquid-solid masses [165] (Table 3).
The flow properties of highly viscous and sticky materials in metal tubes can
be improved by ultrasonic treatment [166]. In the food industry, solutions of
this kind have been used in production of sausages, for instance. In addition,
ultrasound-assisted welding is used in the sintering of cylinders and capsules
[167].
High-intensity ultrasonic devices are used in sonochemistry to modify
material surfaces and properties and to produce amorphous materials [42].
Ultrasound has also been used in the crystallisation of materials since the
beginning of the 70’s [168]. In addition, ultrasound is used in laboratory-scale
textile dying and in melt mixing [169,170]. Dye penetration into fibers can
occur only at temperatures above Tg. It has been reported that ultrasound
does not change the Tg of amorphous materials [171]. It can also be used as
flow enhancer in porous media during filtering and in impregnation.
     20 - 100 kHz
 5 - 10 MHz
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Ultrasound is found to increase paper wetting, because it releases air bubbles
and thus it increased capillary wetting [172]. Wetting is probably increased in
materials that are thick or have a tortuous pore structure. Similarly, the
penetration of liquids into materials with moderate or high contact angles is
increased. In addition, ultrasound increases sorption and diffusion of liquid
into/onto material [173,174]. Ultrasound may also transfer and dislocate
wood fibres [175]. It changes interfaces between phases. Ultrasound is found
to decrease the required operating temperature as well as viscosity and die
pressure in the extrusion process [176]. It was also observed to increase the
mass flow and to produce good appearance of extruded material.
Table 3. Usages of ultrasound in food processing [177].
Mechanical effects Chemical and biological effects
Crystallisation
Degassing
Destruction of foams
Extraction of flavourings
Filtration and drying
Freezing
Mixing and homogenization
Precipitation of airborne powders
Tenderization of meat
Bactericidal action
Effluent treatment
Modification of growth of living cells
Alteration of enzyme activity
Oxidation
Sterilization of equipment
2.6.3 Ultrasound cutting
Ultrasonic cutters were introduced in the food industry during the 1990s.
There are several advantages to ultrasound cutting that explain the current
popularity in the food industry (Table 4). The blades vibrate longitudinally at
a frequency of approximately 20 kHz and the machines are fully automated
[178]. Ultrasound cutters have been used for cutting difficult materials like
soft cream cakes and sticky confectionary. A possible pitfall in ultrasound
cutting is the heating of the ultrasound cutting blade [179] and possible
chemical/physical changes in the cut of surfaces [180]. These changes are
fortunately related to cutting time and power used. Furthermore, ultrasound
cutting blades are more expensive than traditional blades, but it is estimated
that the investment will pay itself back in one year [178]. In the literature
usage of ultrasound cutting in the pharmaceutical industry has not been
described.
-Literature review-
26
Table 4. Benefits of ultrasound cutting compared with a traditional cutting
blade. Modified from Rawson (1998) [178].
Quality of the cut face is visually excellent
The product is virtually undisturbed
Multi-layered products or hard particles contained in a soft matrix can be cut
Smearing is reduced
The required cutting force is significantly reduced
Multilayered products can be cut easily
The blade is self-cleaning
If cavitation is used, it kills bacteria
Crumbs and waste are significantly reduced
Brittle products have less tendency to break
It is cost effective, having low running costs
Less sharp blades are needed and longer intervals between sharpening
than in conventional blades
Can be easily automated
Cutting speeds are similar to conventional methods
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3. Aims of the study
The main aim of the present study was to develope a processing method for
the formulation of a solid dosage form with 200 mg or more of an
amorphous low molecular weight model substance in a single pharmaceutical
unit form. The model substance had a low Tg (below 20 °C) and thus the
formulated materials were sticky in ambient conditions. The diameter of the
dosage form should be less than 9 mm. The formulating method should be
quite economical and simple. The specific aims were:
1. To find a cheap and physically stable amorphous model material for large
scale processing studies that could be used in formulation tests instead of the
actual drug substance of interest, which is sticky, amorphous, highly potent
and expensive;
2. To characterise the physical/chemical properties of this model material;
3. To develop and compare physical testing methods for amorphous materials
and amorphous binary mixtures;
4. To study prerequisites for good physical stability against crystallisation in
amorphous binary mixtures by different analytical methods;
5. To develop a processing method for amorphous materials with a low glass
transition temperature;
6. To gather information for how to measure stickiness and how to avoid it
during processing.
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4. Experimental
4.1 Materials
The model materials used were citric acid anhydrate (CAA) (USP) and
monoclinic paracetamol (PARA) (USP), which were purchased from Hawkins
Inc. (Hawkins Inc., MN, USA) (I-V). Some physical properties of these materials
are shown in Table 5.
Table 5. Physical properties of citric acid anhydrate and paracetamol. Modified
from papers I and V.
Physical property Citric acid anhydrate Monoclinic paracetamol
Molecular structure (a
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1
4
5
OH
6
OOH
OH
O OH
O
5* 6*
  1*
2*3*
4*OH NH
7* 8*CH3
O
Molecular weight 192.1 g/mol 151.2 g/mol
Melting point 153 °C 169 °C
pKa 3.1; 4.8; 6.4 9.4
Glass transition (onset) 11 °C 22.3 °C
Water solubility at 22 °C 10 g/100 ml 0.1-0.5 g/100 ml
Hydrogen bond acceptors -OHalc, -OHac, C=O -OH, C=O
Hydrogen bond donors -OHalc, -OHac -OH, NH
a) Atom numbering as in article V.
4.2 Processing methods
4.2.1 Sample preparation of binary mixtures (I, II, III, IV, V)
Melting was selected as the most suitable method for producing the
amorphous material (I, II, III, IV, V). The melting method is widely used in
pharmaceutical research. However, an ethanol evaporation method was also
tested as a reference to produce amorphous material at a lower processing
temperature than that used in the melting method (II).
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Melt-quenching of bulk materials (I, II)
An electric heating furnace equipped with a temperature controlling system
was used to melt the various blends. Batch size was 50 g and the materials
were added to the furnace at 100 °C. The sample was mixed by hand with a
glass rod. The starting point for melting was defined as the time at which the
sample achieved the target temperature, shown in Table 6. The melt was
poured onto two aluminium pans floating on liquid nitrogen and cooled to
the final temperature of 20 °C ± 10 °C.
Table 6. Experimental design to prepare the most suitable/physically stable
melt-quenched material for processing studies. Modified from paper I.
Composition Melting time 2 min Melting time 6 min Melting time 10 min
PARA % (w/w) 172 °C 179 °C 186 °C 172 °C 179 °C 186 °C 172 °C 179 °C 186 °C
0 x,o  x  x  x  x
25  x,o  x  x  x
50 x  x  x,o  x  x
75  x  x,o  x  x
100 x  x  x  x  x,o
x, test and o, duplicate.
Ethanol evaporation (II)
The ethanol-evaporated materials were pure citric acid, 25/75 and 50/50
(paracetamol/citric  acid anhydrate,  %, w/w).  The sample size used was 6.0 g
of dry materials. The materials were dissolved in 15 g of 96% (V/V) ethanol
(Altia, Rajamäki, Finland). The solution was poured into an aluminum pan on
a thermostatted hot plate (110 °C ± 10 °C ) with a vacuum chamber (100
mbar). The samples were held under these conditions until the residual
weight was from approximately 4% to 10% w/w, after which they were
placed in a vacuum oven (110 °C, 40 mbar). The samples were held in the
oven as long as the residual weight was less than 0.5% (w/w) of the total
weight of added dry powder.
Ultrasound processing (III, IV)
The batch size was 100 g and the composition was 50/50 blend (w/w, %).
Melting time was 6 min at 179 °C ± 2 °C in the heating furnace. The hot melt
was poured into a cylinder (Ø 30 mm) coated with Teflon and the sample was
cooled to room temperature.
Melt blending (V)
PARA and CAA were melted in separate glass beakers after which materials
were mixed and poured onto an aluminium plate. Melting temperatures
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were 163 °C and 179 °C for CAA and PARA respectively. Batch size used was 2
g. The blends contained 25%, 50% or 75% of paracetamol (w/w).
4.2.2 Ultrasound extrusion and cutting (III)
For ultrasound cutting and extrusion, the input of ultrasonic power was
adjusted using an ENI Model 1104LA amplifier and the frequency was set
using an Aitrel/American Reliance Inc. function generator Model FG-506.
Langevin-type piezoceramic sandwich transducers were used in both the
knife and nozzle.
Ultrasound-assisted extrusion
The ultrasound nozzle was constructed to give the maximum ultrasound
amplitude in the longitudinal direction (Figure 7). The nozzle system was
insulated from the sample tank with a hydraulic pipe to maintain a constant
working frequency in the ultrasound nozzle (18.77 kHz). The piston was
driven by pressurized air with a constant pressure of 5.4 bar. The ultrasound
pulse  during  mass  flow  was  60  s  ±  5  s.  The  variability  was  due  to  nozzle
warming-up during the ultrasound pulse. With the help of ultrasound
pulsing, the effect of warming-up of the nozzle on mass flow could be
evaluated. Pulses used during the experiment varied from 3 to 5. Extrudate
was forced through a 3 mm diameter orifice and extrudates were collected
on a moving paper (extrudates were kept separate) or on an aluminium pan
(extrudates were in contact with each other). The factors in the design of the
experiment were the ultrasound power in the nozzle and temperature of the
material in the sample tank and in the ultrasound nozzle (Table 7).
Table 7. Design of the experiments on ultrasound-assisted (A) extrusion and
(B) cutting. Modified from paper III.
(A)   (B)
Power [W]/
Temp. [°C]
0 W 50 W 100 W 150 W  Power [W]/
Temp. [°C]
0 W 50 W 100 W
50 x,o x,o x,o x 25 x x x
60 x,o x,o x,o x 40 x x x
70 x,o x,o x,o -* 50 x x x
60 x x x
x, test, o, duplicate.
*Not measured due to rapid mass flow.
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Figure 7 Schematic cross-sectional representation of the ultrasound equipment
used in the ultrasound extrusion and cutting experiments. Description of
equipment: 1, pre-melting chamber, 2, heating block, 3, sample, 4, piston
driven by 5, pressurised air, 6, hydraulic pipe, 7, ultrasound nozzle with
four piezoceramic sandwiches, 8, extruded material, 9, moving paper, 10,
ultrasonic cutting knife, 11, cut extrudates. Modified from the  patent
application Hoppu (2007) [181].
Ultrasound-assisted cutting
Materials used in the ultrasound-cutting test were extruded at 50 °C without
ultrasound power in the nozzle. Extrudate was collected on a paper sheet.
After extrusion, the extrudate was warmed up to 25 °C, 40 °C, 50 °C, or 60 °C
with warm air (Table 7). After heating the ultrasound knife, working at a
frequency of 24.89 kHz, was used to cut the extrudate into pieces. Ultrasound
power levels used in the knife were 0 W, 50 W or 100 W. The knife was air-
cooled during the cutting process.
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4.3 Analytical methods
4.3.1 High-performance liquid chromatography (I, II, IV, V)
The chemical purity of materials was confirmed using an HPLC (Thermo
Separation Products, San Jose, CA, USA) equipped with an UV-VIS detector
(model FOCUS, San Jose, CA, USA). Wavelengths used for detection were 215
nm for CAA and 245 nm for PARA. The eluent used was composed of 96%
(V/V) water with 0.1% (V/V) trifluoroacetic acid at pH 2.1 and 4% (V/V)
acetonitril. The injection size was 10 µl and the flow rate was 1 ml/min in an
RP-18 column (150 x 4.6 mm, 5 ?m, Supelco, Bellafonte, PA, USA).
4.3.2 Water content analysis (I, II, IV, V)
The amount of water in the samples was measured with a Karl Fischer
titrimetry (Mettler-Toledo AG, model: Dl35, Greifensee, Switzerland).
Hydranal® solvent (Riedel de Haën, Seelze, Germany) was used as a volumetric
solvent and Hydranal® titrant 5 as a volumetric titrant.
4.3.3 Raman scattering (I)
Control Development Raman spectrometer (Control Development Inc., South
Bend, IN, USA) was used to acquire the spectra from 170 cm-1 to  2200 cm-1.
The spectrometer was equipped with a thermoelectrically cooled CCD
detector and a fibre optic probe (RamanProbe, InPhotonics, Norwood, MA,
USA). The power of the laser source was 500 mW at 785 nm (Starbright 785S,
Torsana Laser Technologies, Skodsborg, Denmark). The rotating sample
holder was rotated at approximately 30 rpm during the measurements. The
integration time was 3 s and the median spectrum of three spectra was
constructed based on baseline and standard normal variate (SNV)
transformation [182].
4.3.4 Fourier transform infrared microscopy (I, II, IV)
Fourier transform infrared microscopy (FT-IR) spectra were acquired over a
spectral range of 650 cm-1 to  7500  cm-1 with a Hyperion 1000 microscope
(Bruker Optik GmbH, Ettlingen, Germany). The microscope was used to
identify polymorphs of crystals formed on the material surface. Specular
reflectance spectra were averaged from 64 scans at a resolution of 4 cm-1. The
Kramers-Kronig transformation was carried out using the software package
provided (Opus 5.1, Bruker Optik GmbH, Ettlingen, Germany).
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4.3.5 Thermal analysis (I, II, IV, V)
The glass transition temperature (Tg) of the bulk samples was measured with
a Mettler TA 4000 DSC instrumented with a DSC-30 low temperature cell
(Mettler-Toledo AG, Greifensee, Switzerland) (I). Both onset (extrapolated)
and midpoint values were determined for Tg. Two scans were made for each
sample over the same temperature range from 60 °C to 100 °C. The heating
rate was 10 °C/min and the programmed cooling was used (I).
The in situ melting was carried out by heating the samples in the DSC to
170 °C, 175 °C and 180 °C, after which instant cooling was performed (I).
Furthermore, in situ melting was also done at 179 °C for 6 min. The heating
rate was 10 °C/min. Blends were made in a mortar and pestle before melting.
Samples were prepared with and without a pinhole. The glass transition was
scanned once from -40 °C to +50 °C (I).
Glass transition temperature, heating rate dependence, the specific heat
capacity and physical stability of the material were measured using a Mettler-
Toledo 823e DSC (Mettler-Toledo AG, Greifensee, Switzerland) with a Julabo
FT900 intercooler (Seelbach, Germany) with a pinhole in the sample pan (II,
IV, V).
 In the glass transition measurements, the temperature in the first scan
ranged from -40 °C to 100 °C. The second scan was done from -40 °C to 150 °C
(II, IV, V).
Enthalpic relaxation was measured using hermetically sealed pans. Pure
PARA and CAA samples were melted in situ (chemical purity was more than
98% measured using HPLC). The temperature was 5 °C higher than the
melting temperature and the melting time was 5 min, after which the
samples were cooled to -40 °C at a cooling rate of 10 °C/min. Other samples
used were 50/50 ethanol-produced and 50/50 melt-produced bulk samples.
After cooling to -40 °C the samples were heated to 40 °C and cooled again to
destroy the thermal history. The sample was heated from -40 °C to the
storage temperature and held there for a specific time. The annealing times
were 1, 2, 3, 4, 8, 16, and 24 h, after which the material was cooled again to -
40 °C. The sample was scanned twice from -40 °C to 40 °C to measure
enthalpy recovery in the first scan (?H) and to measure the total enthalpy
recovery in the second scan. Heating and cooling rates were 10 °C/min and
annealing temperatures were 10 or 20 °C lower than Tg (accuracy ±1 °C).
Heating rate dependence was used to charaterise fragility parameters (D
and T0) using the normal DSC mode. Measurements were made as described
by other researchers [93] except that samples were cooled to a temperature
at  40  °C  (not  50  °C)  lower  than  the  Tg.  Tg midpoints were used to define
fragility and activation enthalpies. Heating and cooling rates were: 2, 5, 10,
15, and 20 °C/min.
The specific heat capacity (Cp) was measured using a MDSC from Mettler-
Toledo (TOPEM). The thermal history of samples was destroyed, as in the
enthalpic relaxation measurements. Samples were scanned at a temperature
range of -20 to 40 °C with a heating rate of 1 °C/min, amplitude 0.5 °C and
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frequency variation of 15 to 30 s. The Cp of crystalline blends were measured
from crystalline starting materials weighed directly in the DSC pan in the
right ratio.
4.3.6 X-ray powder diffraction (I, II, IV)
An X-ray powder diffractometer (XRPD) was used to study the solid state of
the materials and to identify polymorphs in the partly crystalline/crystalline
materials (Bruker AXS D8 advance, Bruker AXS GmbH, Karlsruhe, Germany).
The XRPD was operated at 40 kV and 40 mA using CuK? radiation. The
diffraction angle varied from 10° to 40° (2?) with steps of 0.1° per 2 sec. The
reference codes used to identify polymorphs were HXACAN07 for monoclinic,
and HXACAN08 for orthorhombic PARA [183], and  CITRAC10 for CAA, and
CITARC for citric acid monohydrate [184,185] (CSD, The Cambridge
Crystallographic Data Centre, Cambridge, UK).
4.3.7 Resistance to deformation and stickiness (III)
Resistance to deformation and stickiness were tested using a LLOYD material
tester (Lloyd LRX, Lloyd instruments Ltd., Fareham Hampshire, Great Britain)
combined with a specially designed sample compartment (Figure 8). The
purpose of the test was to measure material deformability in compression
and to test the stickiness of the material in decompression. The materials
measured are those listed in Table 6. Melt samples were poured into a
four/five hexagonal nut (Ø 10mm, 7 mm deep), used as a sample holder in
the LLOYD material tester. The nut was screwed into a sample holder, which
was covered with a transparent sample compartment. Heated air was used to
control the temperature in the sample compartment. Measurement
temperatures were 25 °C, 30 °C, 35 °C, 40 °C and 45 °C. The diameter of the
flat steel punch was 5 mm. The steel punch was pushed into the sample 5 mm
and after that pulled off. If a load limit of 90 N was achieved in the
compression, the punch was automatically pulled off from the sample.
Preload in contact was 0.5 N and the driving speed of the punch was 3
mm/min in decompression and compression. The resistance to deformation
was evaluated from the compression curve by calculating the slope (N/mm).
The stickiness was determined from the minimum force (N) in the
decompression curve.
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Figure 8 Schematic representation of the apparatus used to study stickiness and
resistance to deformation: 1, a steel punch driven by 2, the LLOYD
material  tester, 3, heating gas flowing inside the sample compartment 4
through the holes in the bottom 5 or roof, and 6, material in the sample
holder 7 equipped with a thermometer 8.
4.3.8 Rheology (II)
Rheological measurements were made from selected melt-produced samples.
Measurements were carried out using a TA Instruments AR2000 controlled
stress rheometer (TA instruments, DE, USA). For dynamic measurements, the
linear region was established by performing a strain sweep, while frequency
sweeps were made typically in the frequency range of 0.01-100 rad/s. In
steady shear flow measurements, shear rates from 0.1 to 500 1/s were applied
in a controlled rate mode.
4.3.9 Solid state nuclear magnetic resonance (V)
The physical stability of the physical mixtures and amorphous blends were
studied measuring, 1, normal solid-state 13C NMR spectra (result: molecular
interactions from the 13C chemical shifts), 2, rotating-frame spin-lattice
relaxation for protons (T1?) (result: homogeneity of blends), and 3, variable
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temperature measurement (results: molecular mobility and dynamics of the
blend) (Fig. 9). Experiments were done using a Bruker 400 MHz spectrometer
with a wide bore magnet, equipped with a double resonance CPMAS probe
(Bruker Analytik GmbH, Rheinstetten, Germany). The milled samples were
inserted into the Bruker 4 mm rotors (zirconium dioxide rotor with the Kel-F®
endcap). A boron nitride endcap was used in variable temperature
measurements.
13C:
1H:
?/2
DC
CP
13C:
1H:
?/2
RAMP-CP
TPPM
CP
13C:
1H:
?/2
TPPMCPSpin-locking
(A) (B)
(C)
Figure 9 Pulse sequences for (A) CP/MAS 13C 1D spectra, (B) measurement of
temperature dependence for the spectral line width and (C)
measurement of proton rotating-frame spin-lattice (T1?) relaxation. CP,
cross-polarisation, RAMP, ramped mode, DC, proton decoupling, TPPM,
two pulse phase modulation.
4.3.10 Optical and stereo microscopy (IV)
Polarizing light microscopy (DAS Mikroskop Leica Microscopie und Systeme
GmbH, Wetzlar, Germany) was used to study birefringence and the amount
of crystals in the extrudates. An optical stereomicroscope (Leica MZ6, Leica
Mikroskopie und System GmbH, Bensheim, Germany) was used to compare
the appearance of differently prepared extrudates.
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4.3.11 Aging study (I, II, IV)
After sample preparation (bulk and ethanol evaporated materials) aluminium
pans were placed in silica desiccators with a relative humidity (RH) of approx.
3% to stabilise for 12 hours (I, II). Samples were then characterised by HPLC,
FT-IR, XRPD, Karl Fischer titration, DSC, and Raman scattering. After this
initial characterisation, one sample pan was exposed to 43% RH (desiccator
containing K2CO3 solution) and the other pan was placed in a desiccator over
a dry silica desiccant. Samples in 43% RH were analysed at 1, 4, 8, 12, and 18
weeks after melting, whereas the dry samples were analysed after 9, 18, 27,
52 and 104 weeks with FT-IR, XRPD, Karl Fischer titration, and Raman
spectroscopy.
Ultrasound treated materials were characterised after 1, 4, 8, 16, 26 and 52
weeks of storage over silica desiccant (IV). Samples used in the enthalpic
relaxation study (II) were stored in dry conditions at -20 °C for one year after
which they were measured with DSC to check their physical stability.
4.3.12 Statistical methods (I, II, III, IV, V)
The design of the experiments and data analysis were made by the Modde
programme version 7.0 (Umetrics AB, Umeå, Sweden). Spectral and DSC data
were evaluated with multivariate data analysis using Simca-P version 10.5
(Umetrics AB, Umeå, Sweden). The designs of the experiments were based on
the full factorial interaction models described in papers I, III and IV. In DSC
thermograms, Raman and FT-IR spectra, the median of thermograms/spectra
was selected and shown in the figures.
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5. Results and discussion
More detailed results and discussions can be found in the respective papers (I-
V). A schematic approach used in the present study the physically stable
amorphous binary mixtures with low glass transition temperatures and other
process materials of this kind is shown in Figure 10.
Sample preparation (I, II,V)
Characterisation (I, II,V)
Processing of sticky material (III) b
(ultrasound cutting and extrusion)
Characterisation of formulations (IV)
In situ melting (0.01 g)a, Melting method (50 g)a
Ethanol evaporation (6 g)a, Melt blending (2 g)a
Glass transition temperature
Physical stability
Rheology
ssNMR
Chemical purity
Factors for good
physical stability:
Fragility parameters
Molecular mobility
Molecular interactions
Homogeneity
Degradation products
Figure 10 A schematic description of the study plan used in this study. (a) Batch size,
(b) melting method using a batch size of 100 g.
5.1 Effect of composition and sample preparation method
on amorphous binary mixtures
5.1.1 Glass transition temperature (I, II, IV, V)
In all the differently prepared materials, Tg was observed to increase as the
ratio of PARA increased (Figs. 11 and 12). The Tg of materials prepared by the
melt blending method, was found to be higher than in materials with the
same composition but prepared by other production methods. This was due
to a smaller amount of degradation products formed in the melt-blended
materials than in other materials (I, II, V). Batch size during melting of CAA
has an effect on the amount of degradation products [186,187]. It is known
that volatile degradation products are difficult to evaporate from citric acid
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blends [188], possibly due to the high hydrogen bonding capacity of CAA and
high viscosity of the melt.
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Figure 11 Effect of batch size and amount of paracetamol (w/w, %) on glass
transition temperature. Modified from papers I, IV and V.
In melt-blended blends, the measured Tg’s were higher than the one
estimated from the simple additivity of Tg (calculated using Fox equation
[189]) while in the bulk-prepared materials the blends had lower values. The
positive deviation from the simple additivity of Tg has been reported
previously [109]. The negative deviation from the simple additivity of Tg was
related to the degradation products formed during sample preparation.
Underestimation was observed especially in the in situ materials measured
without a pinhole (I). For melt-blended materials, Tg
mid values were 16.3 °C
and 19.3 °C, for 25% of PARA (w/w) and 50/50 blend, respectively. These Tg
mid
values were slightly higher than observed for bulk-prepared blends with the
same composition, where values for Tg
mid were 14.7 °C and 17.9 °C,
respectively (I, II). For the ultrasound processed 50/50 reference material, Tg
mid
was 15.3 ± 0.2 °C (III). Differences in Tg might be related to the higher melting
temperature and longer melting time for bulk-prepared materials than for
melt-blended materials. In all the blends, CAA was found to be more sensitive
to degradation than PARA but it was also dependent on the composition (I,
II).
The extreme melting conditions, coupled with the long exposure to heat
and the high melting temperature, increased the degradation products in the
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material as expected. The chemical purity of materials has an effect on Tg
because degradation products may plasticise the material and thus purity has
an effect on the Tg (I). The smaller amount of degradation products in melt-
blended materials than in bulk-prepared materials was confirmed in HPLC
analysis and it was also seen in 13C NMR spectra, where no extra peaks were
observed. This kind of melt blending method has also been described
elsewhere in preparation of amorphous solid dispersions [190]. Thus,
production scale and preparation method has an effect on the amount of
degradation products formed and thus on the Tg.
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Figure 12 Glass transition of melt-blended materials compared with the in situ
prepared pure PARA and CAA. In the upper DSC thermograms,
crystallisation of in situ PARA and melting endotherms of in situ PARA
(orthorhombic form) and the blend containing 75% PARA (w/w) are also
presented.
5.1.2 Physical stability against crystallisation (I, II, IV, V)
The crystallisation of amorphous materials happened faster over 43% RH
than over 3% RH (Table 8) (I). This was probably related to the fact that
water plasticise the material. Water may also change molecular interactions
in the material because water is a potent hydrogen bond-competitor.
Changes in hydrogen bonding between molecules can induce crystallisation.
Crystallisation started on the surface of the amorphous material. This
finding supports the key role of water in crystallisation because the surface
has the best contact with the humid air. In addition, re-crystallisation re-
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distributes the water in the partly crystalline material because an amorphous
state holds more water than a crystalline state [191]. Redistribution of water
plasticises the rest of amorphous matrix, which accelerates the crystallisation
rate due to decreased viscosity (increased molecular mobility). Similar results
have also been observed for e.g. indomethacin [192]. Furthermore, the water
uptake of a crystalline biphasic system (citric acid anhydrate/sucrose) has been
found to be higher than for the individual components [193]. This might also
occur in our CAA/PARA mixtures where amorphous blends
absorbed/adsorbed more water than, for example, pure partly amorphous
CAA (I). The blends were observed to be physically more stable than the pure
materials in the aging studies. The melting conditions were found to have a
minimal effect on the overall crystallisation rate (I). PARA had a stronger
tendency to crystallise from the blends than CAA when studied with FT-IR
microscopy (II) and ssNMR (V).
In DSC studies (Figs.  11 and 12),  it  was found that materials  containing a
high amount of PARA or pure CAA crystallised more easily than other
materials (I, II, V). Furthermore, storage time before measurement had an
effect on the crystallisation during DSC scan. This was extremely well seen in
the pure CAA that did not crystallise in in situ melting studies, but the bulk-
prepared CAA crystallised easily during the DSC scan. This was related to the
crystals formed in the materials that had been formed due to ineffective
cooling or storage.
Table 8. Physical stability of materials prepared by different methods. Letters
stand for different samples with different batch size that were
observed to crystallise during sample preparation, material
measurement or aging: a) bulk 50 g, b) ethanol 6 g and c) melt
blending 2 g. Modified from papers I, II, V.
Sample preparation Measurement Aging at RH(ii)
w/w
(%)
PARA In situ(i)
During
preparation(ii) DSC(i) Rheometer(ii)
1 week
at 43%
4 weeks
at 43%
52 weeks
at 3%
104
weeks
at 3%(iii)
0  -  a a a a, b  + + +
25  -  -  - a  -  +  - -
50  -  -  -  -  -  +  - -
75  - b + +  a, b +  b +
100 + + + + +  + + +
-, materials did not crystallise during preparation, measurement or aging.
+, all the materials crystallised regardless of preparation method
i, material crystallised during the first DSC scan
ii, physical stability measured by XRPD
iii, only 50 g bulk-prepared materials were measured
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Consecutive shearing at different temperatures was found to be an
extremely effective method to crystallise unstable blends and it was observed
to correlate with the actual physical stability during long-term storage in dry
conditions (Fig. 13) (II). In dry conditions, amorphous bulk-prepared blends
(25/75 and 50/50) were found to still be amorphous after at least two years
when measured by XRPD (II).
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Figure 13 XRPD analysis of melt-produced bulk materials (a) after two years storage
over dry silica, (b) after consecutive shearing.
The 50/50 (w/w, %) blend did not crystallise upon consecutive shearing
regardless of the preparation method (II). Ethanol evaporated materials
(physically stable from 0 to 50 wt-% PARA) and melt-blended materials (25 to
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50 wt-% PARA) were observed to be more stable upon consecutive shearing
than the 50 g bulk-prepared materials. This might be related to the more
homogeneous blends of these materials resulting in a lack of formed crystals.
Karis and co-authors (1995) [194] reported shear-induced crystallization
during viscosity measurement. Their explanation was the coupling between
molecules with hydrogen bonds induced by external strain. Alignment is
observed to form shorter hydrogen bonds that improve hydrogen bond
stability against shearing [195]. CAA crystallises owing to the dimerisation of
carboxylic acid groups of CAA (I). Dimerised carboxyl acid has particularly
strong hydrogen bonds. After shearing, pure CAA had high intensities in
XRPD diffractograms at 16.5° and 19.5°, which were connected to the
dimerisation of CAA (I). Alignment under shear has also reported to form
relatively strong van der Waals forces in fats [196]. Similarly, alignment of
PARA molecules is needed to form unit cells of monoclinic PARA where
relatively strong van der Waals forces are crucial. Thus, batch size and
processing method have a huge impact on physical stability. The chemical
stability of blend materials decreased approximately 5% from the initial level
during two years storage in dry conditions.
5.1.3 Rheology (II, V)
Viscosity of materials as a function of temperature is shown in Fig. 14.
Viscosity was observed to increase as the amount of PARA in the composition
increased. It can be seen that ethanol evaporated materials had lower
viscosity than melt-processed materials.  Furthermore, the dynamic moduli (G'
and G'') of melt-produced blends were found to be slightly higher than for
ethanol evaporated materials (II). The viscosity of melt-blended materials was
slightly higher than that of bulk-prepared materials, probably due to a small
amount of degradation products or water in the materials. Generally, it was
found that the degradation products of CAA and PARA had only a minor
effect on viscosity when similarly prepared materials were compared.
Viscosity was more dependent on the preparation method due to changes in
the amount of degradation products formed. Water content of the 50/50
melt-blended material was approximately 0.7% (w/w) while in the bulk-
prepared material it was approximately 1.2% (II, V). All the materials behaved
as viscous Newtonian liquids. For all the materials measured, the extrapolated
viscosity at the Tg
mid lower than the often quoted 1012 Pa·s for glassy materials
[56].
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Figure 14 Reciprocal temperature plot of viscosity of: ethanol-evaporated materials,
citric acid (?),  25  wt%  (×),  50  wt%  (?) PARA/CAA mixture; and melt-
processed 50 wt% (o) bulk material, and melt-blended 25 wt% (?), 50
wt% (?) PARA/CAA mixture. Dashed lines are fit of VTF equation to the
data between 40-80 °C. Modified from papers II and V.
Due to the limited torque range of the rheometer, only data at low shear
rates could be measured at 40 °C and 50 °C. In steady shear flow
measurements, when higher shear rates were applied, the materials exhibited
noticeable shear thinning, which probably resulted from slipping of the
rheometer plate, especially as shear thinning was not observed in the
oscillatory data up to 100 rad/s. Several possible sources of experimental error
in rheological measurements have been reported [196,197]. Poor contact
between the plate and material produces different velocities for the sample
and the plate. Usually, small molecules are locked within surface
irregularities, but for molecules larger than the irregularities, slippage may
occur [196,198]. Slippage can be avoided by using different widths of plates
or by using roughened or ribbed plate surfaces [197,198].  In this study, only
one plate size with a normal steel surface could be used, which might have
produced the slippage.
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5.2 Factors affecting physical stability of amorphous binary
mixtures
The 50/50 (%, w/w) blend was observed to be physically the most stable
system regardless of the preparation method (Table 8). The 50/50 mixture did
not crystallise as easily under dry conditions or upon consecutive shearing as
the other compositions. The reasons for this behaviour are discussed below.
5.2.1 Fragility parameters (II, V)
Composition and preparation and measurement methods were found to have
an effect on fragility parameters (II). Pure materials had lower fragility
parameters than the blends when similar measurement settings were used.
Materials with a high D value formed glass more easily than materials with a
low D value [80]. However, small changes in the viscosity had a huge effect
on observed D and T0 values.  In Fig. 14, the D value is 6.6 for the 50/50 bulk
and 11.8 for 25% (w/w) melt-blended material, although the viscosity curves
were quite similar. Similarly, T0 values were 241.9 K and 218.8 K, respectively.
Furthermore, fragility parameters reported in the literature vary
considerably even when similar thermal methods are used. For example, D
values reported for paracetamol range from 4.9 to 9.3 and T0 from 240.5 K to
260.3 K [118,199]. Similarly, the fragility values for citric acid vary from 5.6 to
15.0 and T0 from 200.7 K to 249 K [93,98]. In addition, calculated D and T0
values usually vary between different measurement methods [200] because
different methods probe different modes of molecular motion. Water
content in the material has also effect on fragility parameters defined
probably due to changes in molecular interactions [201]. Differences in the
defined parameters used in the molecular relaxation equations might have a
huge effect on evaluated ? [93].
5.2.2 Molecular mobility (II, V)
Because molecular mobility in the blends was fast (?<100 s), it did not explain
the good physical stability of the 50/50 blend against crystallisation at
ambient temperature (II,V). All the materials were stable at least one year in
dry conditions at -20 °C as expected from the molecular relaxation times
evaluated (II). At temperatures below the Tg, molecular mobility was observed
to be slow and molecular relaxation times were observed to lengthen during
the annealing time (II). Although different fragility parameters were used, it
was observed that the molecular relaxation time of the 50/50 blend was
lower than the ? of the pure materials at temperatures below Tg (II).
Molecular relaxation times ?KWW and ?0 were higher for pure PARA than for
the blends (Table 9) (?KWW is not shown, because the differences in the ? values
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does comparisons between materials difficult). This differed from the actual
physical stability at temperatures above Tg (II).
Although CAA/PARA blends (25% PARA and 50% PARA, w/w, 50 g
materials) were supercooled melts at approximately 25 °C, they were still
amorphous according to XRPD after two years of storage in dry conditions,
even though ? was less than 100 s (II) (Tables 9 and 10). Thus, there must be
factors other than the molecular mobility that stabilise the amorphous state.
Other molecules have also been found to be physically stable in the
supercooled liquid state, such as o-terphenyl (Tg = 245 K), which has been
reported to be physically stable at ambient conditions for many years [51].
Molecular mobility estimated above Tg correlated well with the viscosity data
(II). Similarly, ? evaluated from the viscometer data correlated well with the
actual physical stability of the materials. Possible reasons for the good
physical stability of these materials are high viscosity and a ? just above the
solidification point after melt quenching, as proposed by White and
Cakebread (1984) [56].
Table 9. Rheometrically and calorimetrically determined values for ?, Tgmid, D, T0
and ? of amorphous materials used.
Material/
parameter
Tg
mid
[K]
D  T0
[K]
? (c) ?0 at 253 K (e)
[days]
? at 298 K (f)
[s]
? at 323 K (f)
[s]
(c) PARA 293.9 9.9 231.4 0.86 13.3 8.04 7.0 · 10-4
(c) CAA 284.9 11.8 215.9 0.90 0.7 0.28 2.1 · 10-4
(c) 50/50 melt (a) 287.3 14.9 204.5 0.91 0.6 1.35 1.4 · 10-3
(c) 50/50 melt (b) 292.5 18.5 194.6 0.89 1.4 13.29 1.5 · 10-2
(d)50/50 melt (a) 287.3 6.6 241.9 0.91 0.6 0.02 3.4 · 10-6
(d) 50/50 melt (b) 292.5 11.1 227.1 0.89 2.4 24.60 2.4 · 10-3
a Bulk samples, batch size 50 g
b Melt blending, batch size 2 g
c Calorimetrically  determined
d Rheometrically determined
e Calculated by Eq. 5 (initial relaxation time)
f Calculated by Eq. 6 (VTF)
The average correlation time for molecular mobility obtained from the
spectral line width measurements with ssNMR correlated better with the ?
derived from a rheometer than with ? derived from a DSC data (V) (Table 10).
In the ssNMR study, the maximum spectral linewidth was observed at
approximately 325 K, corresponding to an average correlation time for
molecular mobility of 2.0?10-5 s to 1.9 ·10-6 s. Decoupling field was observed to
be the dominating interaction giving an average correlation time <?> of
1.9?10-6 s  (V).  Small  changes  in  the  measured  water  content  and  Tg of the
material might have altered the viscosity observed, having an effect on
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evaluated molecular relaxation times. Furthermore, it is well known that
different measurement methods probe slightly different molecular mobilities
and there is some uncertainty in measured results especially when fragility
parameters are used.
Table 10.  Effect of measurement temperature, batch size and measurement
method on the molecular relaxation times (?) observed for the
amorphous 50/50 blend measured by DSC and rheometer. Fragility
parameters used in the calculations (Eq. 6, VTF) are shown in Table 9.
Modified from papers II and IV.
Molecular relaxation time (?)
50/50
Bulk material
50/50
Melt blending
Temp. [K] DSC
[s]
Rheometer
[s]
DSC
[s]
Rheometer
[s]
295 4.0 0.10 3.8?101 1.1?102
305 0.14 8.9?10-4 1.5 1.0
315 9.1?10-3 2.9?10-5 9.8?10-2 2.6?10-2
325 9.3?10-4 2.1?10-6 9.9?10-3 1.4?10-3
335 1.3?10-4 2.7?10-7 1.4?10-3 1.3?10-4
345 2.6?10-5 5.1?10-8 2.5?10-4 1.8?10-5
355 6.1?10-6 1.3?10-8 5.7?10-5 3.5?10-6
5.2.3 Molecular interactions (I, II, V)
Molecular interactions were studied using ssNMR, FT-IR microscopy, Raman
scattering and XRPD. Different spectroscopic methods confirmed detectable
changes in amorphous and crystalline forms of CAA/PARA blends. Bands
observed using FT-IR microscopy, ssNMR, and Raman spectroscopy were
merged together in some spectral regions in the amorphous state. This was
due to more mixed molecular interactions in the blends than in the crystalline
pure substances. In particular, a lack of dimerised carboxylic acid groups of
CAA in the amorphous blends was observed (I, V) (Fig. 15). In addition, peak
shift variation in ssNMR and FT-IR spectra resulted from changes in the
molecular interactions. These were especially seen in ssNMR spectra where
alcoholic groups of CAA and PARA moved higher frequencies, describing
probably stronger hydrogen bonds in the amorphous state than in the
crystalline state (V) (Fig. 15). A low frequency shift of amide (CNH, peak 1* in
Table 5) of PARA might be the result of extremely weak hydrogen bonding in
the blend and the apparent low frequency shift of the carboxylic acid of CAA
could be due to the loss of dimerisation of the carboxylic acid.
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(i) (ii)
 b
          a   c
Figure 15 Molecular interactions in crystalline (i) citric acid anhydrate (CITRAC10)
[185] (ii) monoclinic paracetamol (HXACAN07) [183]. Molecular
interactions: b,  dimerisation of carboxylic acids, a, alcoholic -OH of CAA
and c, alcoholic –OH of PARA.  Modified from papers I and V.
There are more opportunities to form hydrogen bonds in CAA than in
PARA, which may have an effect on molecular interactions. Therefore, the
crystallisation rate of pure CAA is slower than that observed for pure PARA
(I). Molecules with multiple hydroxyl groups, such as sugars, are known to
produce amorphous form quite easily [85]. The aromatic ring is reported to
cause steric hindrance that restricts the hydrogen bond network from
growing uniformly in one direction in m-toluidine glass [108]. This could be
one explanation for why blends are physically more stable than pure
materials in our study. Apparently, a blend should be less ordered than a
pure substance, which could have an effect on the crystallisation rate. Thus,
molecular interactions such as hydrogen bonds combined with van der Waals
forces might have an effect on the crystallisation tendency of amorphous
materials (I, V), at least within amorphous blends with a low Tg.
5.2.4 Homogeneity of materials (I, II, V)
For all the materials measured, a single glass transition temperature was
observed indicating the good miscibility of the blends. However, DSC is not
the most sensitive method to measure miscibility of the blend [202]. Proton
rotating-frame spin-lattice relaxation constants (T1?) were quite similar when
probed via different 13C atoms in the amorphous blend, confirming a good
homogeneity in the blends. However, the standard deviation in the T1? was
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found to be smaller for the 50/50 (w/w, %) blend than for other blends,
which might be related to the better miscibility of this system compared with
other systems. Thus, the crystallisation tendency of blends such as 75/25
(PARA/CAA, w/w) might be related to a lack of homogeneity due to
ineffective blending. Similar behaviour in changes of spectral linewidth as a
function of measurement temperature in the ssNMR study revealed similar
dynamics for citric acid anhydrate and paracetamol in the amorphous 50/50
blend. This result confirmed the good homogeneity of the material, which
was a prerequisite for good physical stability of the 50/50 blend.
5.2.5 Other prerequisites for physical stability (I, II, V)
There might also be some other factors that are important for stabilising the
amorphous binary mixtures besides molecular interactions and good
homogeneity of materials, such as the thermodynamic and crystallisation
driving forces (II, V). Especially formation of the “eutectic mixture” (i.e.
physical mixture of 50/50 blend has the lowest melting point) of the
CAA/PARA blend [109] might be a key factor leading to a decrease in the
thermodynamic driving force for crystallisation [203] of the 50/50 blend.
One possible reason for this could be the high viscosity of the 50/50 blend
just above the Tg as seen in paper II. In the blends, there is always more than
one molecular species, increasing the mismatch between molecular networks.
Similarly, the benzene ring of PARA may cause steric hindrance in the blends
and stabilise electrostatic forces with other electron donating groups, as
suggested by Timko (1979) [109]. Differences in Tg cannot be the reason for
the good physical stability of the blends because the blends had lower Tg’s
than pure PARA, but nonetheless PARA was more stable in the blends than as
a pure substance. A similar effect has been reported for a case where glycerol
increased the chemical stability of a material, even though the Tg decreased
and molecular mobility increased [204]. Similarly, small amount of water in
the material, i.e. no plasticising effect,  has been suggested to be beneficial in
amorphous material because of possible changes in free volume or structure
of material [204,205].
5.3 Ultrasound-assisted processing
Thus far, researchers have been interested in drugs having a glass transition
higher than ambient temperature, because drug systems having a low Tg are
thought to be physically too unstable and difficult to handle and process in
an industrial scale. Thus, a new processing method was developed and
patented for a sticky/viscous amorphous material.
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5.3.1 Extrusion (III)
Figure 16 shows the effect of ultrasound power and material temperature on
mass flow through a 3 mm orifice. Mass flow through the nozzle improved
when the temperature or the ultrasound power were increased. The effect of
ultrasound on mass flow was not related to the warm-up of the nozzle due
to instantaneous changes in the mass flow as the ultrasound power was
switched on or switched off. The main reasons for better material flow due to
ultrasound may be lower viscosity due to changes in the surface properties of
the material and a reduction in the surface friction between metal and
material. Similar results have been described in polymer and food studies
[166,176]. A decrease in friction has been found to increase die durability and
to produce a better surface on the processed extrudates in polymer extrusion
[176,206]. Air bubbles in the material were problematic during the processing
because they started to oscillate when ultrasound power was used, and this
breaks down the extrudate. This effect was extremely strong if there was a
high amount of bubbles in the material.
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Figure 16 Effect of ultrasound power (W) on mass flow as a function of
temperature (°C) through an ultrasound assisted nozzle. Modified from
paper III.
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5.3.2 Cutting (III)
The 50/50 blend was found to be sticky in our probe tack test but it was
possible to handle this material with ultrasound. The reasons for stickiness
(III) were assumed to be: glass transition, viscosity, time-dependent wetting
and surface energetics.
Ultrasound cutting was found to be a good method of cutting amorphous
sticky model material compared with traditional cutting where the material
stuck to the blade (Table 11). Different ultrasound power levels (50 and 100
W) were not observed to have an effect on the quality and appearance of cut
extrudates. The best cutting temperature for this material was found to be
approximately 40-50 °C because it gave nice sharp corners for the extrudate
cuts.
One reason why ultrasound decreased the stickiness was that the vibrating
metal surface decreases the contact time needed to achieve good wetting on
the blade. The other possible reason was the bubbles in the cracks on the
blade surface. These air bubbles started to cavitate/oscillate when ultrasound
was used [162], hindering contact between the knife and sticky material. One
possible problem in ultrasound cutting has been the heat generated by the
cutting [179]. However, the cutting time would have to be rather long,
whereas the cutting process normally only requires milliseconds.
The average weight of the 5 mm long extrudate was approximately 13
mg. These units can be used to fill capsules. Approximately 200 mg of drug
could be processed into a single extrudate/dosage form if the diameter of the
orifice in the nozzle is increased to 8 mm and length of extrudate would be
10 mm. This size of extrudate could be used to fill capsules or could be
further processed by coating.
Table 11. Effect of ultrasound on sticking of extrudate to the knife (yes / no) a
and appearance of the edge of the extrudate (broke down during
cutting / sharp / round / squashed) b.
US* power [W]/
Cutting temp. [°C]
0 W 50 W 100 W
25 °C (a) yes
(b) broke down
(a) no
(b) broke down
(a) no
(b) broke down
40 °C (a) yes
(b) squashed
(a) no
(b) sharp
(a) no
(b) sharp
50 °C (a) yes
(b) squashed
(a) no
(b) sharp
(a) no
(b) sharp
60 °C (a) yes
(b) squashed
(a) no
(b) round
(a) no
(b) round
* US, ultrasound
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5.3.3 Effect of ultrasound on physical stability of materials (IV)
The ultrasound assisted extrusion and cutting did not accelerate the
crystallisation rate of processed materials (IV). A possible reason why these
materials did not crystallise during ultrasound treatment was the short
contact time with ultrasound and a high viscosity at the processing
temperature. Ultrasound treatment has been reported to have an effect only
on the surface of viscous liquids and then treatment time should be long (at
least 60 s) to trigger crystallisation [207]. Thus sonocrystallisation processes
are done in liquids with low viscosity such as water [43] (viscosity = 10-3 Pa·s at
20 °C). Furthermore, cavitation is one of the main factors in the
sonocrystallisation process [43,177] but in viscous liquid, cavitation might not
occur because microbubbles are unlikely to form due to the viscosity.
Ultrasound cutting and extrusion proved to be useful method for
processing amorphous materials and amorphous binary mixtures, provided
that the material was sufficiently physically stable against mechanical and
thermal stress. In addition, ultrasound as a processing aid could be used to
increase the processability of sticky solid dispersions.
A patent application for ultrasound-assisted extrusion and cutting for
pharmaceutical use has been filed based on the results reported in this study
[181].
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6. Conclusions
A blend of citric acid anhydrate (CAA) and paracetamol (PARA) (50/50, %,
w/w) was observed to be a good amorphous model substance with a low
glass transition temperature for the large scale processing studies.
The composition of the blend and material exposure to water were found
to be critical factors affecting the physical stability (i.e. crystallisation) of the
amorphous materials. Molecular mobility was not observed to be the main
factor for stabilisation of CAA/PARA blends because the molecular relaxation
time was less than 100 s in ambient conditions. The factors responsible for the
good physical stability of the 50/50 blend were good homogeneity and the
molecular interactions in the amorphous binary mixture, and these
underlying reasons for its physical stability could be effectively evaluated
using ssNMR spectroscopy. Other important factors included the
thermodynamic driving force i.e. the formation of the “eutectic mixture”.
The good physical stability of the 50/50 blend was not related to degradation
products. Initial consecutive shearing after sample preparation was found to
correlate with the actual physical stability of the materials in long-term
storage in dry conditions.
Composition and temperature affected stickiness and deformability of the
material. Stickiness was especially dependent on the glass transition and
viscosity. With the help of ultrasound extrusion and cutting, it was possible to
process sticky amorphous material in the supercooled liquid state. In addition,
ultrasound treated materials were not found to crystallise more rapidly than
untreated materials during one year of storage in dry conditions. Thus,
ultrasound extrusion and cutting are extremely promising processing
methods for viscous and sticky material.
-References-
54
7. References
[1] Y. Roos, Phase transitions in foods. Academic press, Inc., USA, 1995, p 360.
[2] B. C. Hancock, G. Zografi, Characteristics and significance of the amorphous state
in pharmaceutical systems, J. Pharm. Sci.  86 (1997) 1-12.
[3] M. C. Lai, E. M. Topp, Solid-state chemical stability of proteins and peptides, J.
Pharm. Sci.  88 (1999) 489-500.
[4] Ö. Almarsson, C. R. Gardner, Novel approaches to issues of developability,
Current Drug Discovery  3 (2003) 21-26.
[5] D. Singhal, W. Curatolo, Drug polymorphism and dosage form design: a practical
perspective, Adv. Drug Del. Rev.  56 (2004) 335-347.
[6] G. L. Amidon, H. Lennernäs, V. P. Shah, J. R. Crison, A theoretical basis for a
biopharmaceutic drug classification: The correlation of in vitro drug product
dissolution and in vivo bioavailability, Pharm. Res.  12 (1995) 413-420.
[7] R. K. Verma, S. Garg, Current status of drug delivery technologies and future
directions, Pharm. Tech. On-line 25 (2001) 1-14.
[8] S. Richton-Hewett, E. Foster, C. S. Apstein, Medical and economic consequences
of a blinded oral anticoagulant brand change at a municipal hospital, Arch. Intern.
Med.  148 (1988) 806-808.
[9] K. Inoue, K. Ogawa, J. i. Okada, K. Sugibayashi, Enhancement of skin permeation
of ketotifen by supersaturation generated by amorphous form of the drug, J.
Control. Release  108 (2005) 306-318.
[10] G. G. Z. Zhang, D. Law, E. A. Schmitt, Y. Qiu, Phase transformation
considerations during process development and manufacture of solid oral dosage
forms, Adv. Drug Del. Rev.  56 (2004) 371-390.
[11] C. R. Gardner, C. T. Walsh, Ö. Almarsson, Drugs as materials: Valuing physical
form in drug discovery, Nat. Rev. Drug Discovery  3 (2004) 926-934.
[12] Pfizer, Pfizer Annual Report 2006, ed., Pfizer Inc., 2007  p 84.
[13] P. R. Rose, J. A. Leonard, Process form forming amorphous atorvastatin calcium,
WO 2005/100313 A1 (2004).
[14] A. T. M. Serajuddin, Solid dispersion of poorly water-soluble drugs: early
promises, subsequent problems, and recent breakthroughs, J. Pharm. Sci.  88 (1999)
1058-1066.
[15] K. Yamashita, T. Nakate, K. Okimoto, A. Ohike, Y. Tokunaga, R. Ibuki, K. Higaki,
T. Kimura, Establishment of new preparation method for solid dispersion formulation
of tacrolimus, Int. J. Pharm.  267 (2003) 79-91.
[16]  P.  M.  V.  Gilis,  V.  F.  V.  De  Conde,  R.  P.  G.  Vandecruys,  Beads  having  a  core
coated with antifungal and a polymer WO9405263A1 (1993).
[17] C. A. Bailey, J. C. Ferdinando, Pharmaceutical composition comprising a
proteinase inhibitor and a monoglyceride, WO9639742A1 (1996).
[18] A. M. Kaushal, P. Gupta, A. K. Bansal, Amorphous drug delivery systems:
Molecular aspects, design, and performance, Crit. Rev. Ther. Drug. Carrier Syst.  21
(2004) 133-193.
[19] B. C. Hancock, Disordered drug delivery: destiny, dynamics and the deborah
number, J. Pharm. Pharmacol.  54 (2002) 737-746.
[20] C. L. Stevenson, D. B. Bennett, D. Lechuga-Ballesteros, Pharmaceutical liquid
crystals: The relevance of partially ordered systems, J Pharm. Sci.  94 (2005) 1861-
1880.
-References-
55
[21] C. J. Roberts, P. G. Debenedetti, Engineering pharmaceutical stability with
amorphous solids, AIChE Journal  48 (2002) 1140-1144.
[22] W. L. Chiou, S. Riegelman, Pharmaceutical applications of solid dispersion
systems, J. Pharm. Sci.  60 (1971) 1281-1302.
[23] J. L. Ford, The current status of solid dispersions, Pharm. Acta Helv.  61 (1986)
69-88.
[24] H. R. Guzmán, M. Tawa, Z. Zhang, P. Ratanabanangkoon, P. Shaw, C. R.
Gardner, H. Chen, J.-P. Moreau, Ö. Almarsson, J. F. Remenar, Combined use of
crystalline salt forms and precipitation inhibitors to improve oral absorption of
celecoxib from solid oral formulations, J. Pharm. Sci.  96 (2007) 2686-2702.
[25] W. Wang, Lyophilization and development of solid protein pharmaceuticals, Int.
J. Pharm.  203 (2000) 1-60.
[26] R. A. Beyerinck, R. J. Ray, D. E. Dobry, D. M. Settell, Method form making
homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles.,
WO03/063821A2 (2003).
[27] R. A. Beyerinck, R. J. Ray, D. E. Dobry, D. M. Settell, K. R. Spence, H. L. M.
Deibele, Method for making homogeneous spray-dried solid amorphous drug
dispersions utilizing modified spray-drying apparatus, WO0363822A2 (2003).
[28] Z. Yu, K. P. Johnston, R. O. Williams, Spray freezing into liquid versus spray-
freeze drying: Influence of atomization on protein aggregation and biological
activity, Eur. J. Pharm. Sci.  27 (2006) 9-18.
[29] O. L. Sprockel, M. Sen, P. Shivanand, W. Prapaitrakul, A melt-extrusion process
for manufacturing matrix drug delivery systems, Int. J. Pharm.  155 (1997) 191-199.
[30]  L.  Yu,  D.  S.  Mishra,  D.  R.  Rigsbee,  Determination of the glass  properties  of  D-
mannitol using sorbitol as an impurity, J. Pharm. Sci.  87 (1998) 774-777.
[31] D. Giron, Characterisation of salts of drug substances, J. Therm. Anal. Cal.  73
(2003) 441-457.
[32] L. Yu, Amorphous pharmaceutical solids: preparation, characterization and
stabilization, Adv. Drug Del. Rev.  48 (2001) 27-42.
[33] J. K. Guillory, Generation of polymorphs, hydrates, solvates, and amorphous
solids, in: H. G. Brittain, editor Polymorphs in pharmaceutical solids: Marcel Dekker,
Inc., NY, USA 1999,  pp 183-226.
[34]  Y.  Li,  J.  Han,  G.  G.  Z.  Zhang,  D.  J.  W.  Grant,  R.  Suryanarayanan,  In  situ
dehydration of carbamazepine dihydrate: A novel technique to prepare amorphous
anhydrous carbamazepine, Pharm. Dev. Tech.  5 (2000) 257-266.
[35]  J.  E.  Patterson,  B.  J.  Michael,  A.  H.  Forster,  R.  W.  Lancaster,  J.  M.  Butler,  T.
Rades, The influence of thermal and mechanical preparative techniques on the
amorphous state of poorly soluble compunds, J. Pharm. Sci.  94 (2005) 1998-2012.
[36] T. J. Smith, G. Gauzer, High pressure compaction for pharmaceutical
formulations, WO2004058222A1 (2003).
[37] S. Weinhold, M. Litt, J. B. Lando, The effect of crystallite on the electric field
induced ??to?? crystals phase transition in poly(vinylodene fluoride), Ferroelectrics  57
(1984) 277-296.
[38] S. F. Swallen, K. L. Kearns, M. K. Mapes, Y. S. Kim, R. J. McMahon, M. D.
Ediger, T. Wu, L. Yu, S. Satija, Organic glasses with exceptional thermodynamic and
kinetic stability, Science  315 (2007) 353-356.
[39] S. Szoke, C. Szabo, L. Gyuricza, C. Singer, V. Niddam-Hildesheim, G.
Sterimbaum, Process for preparation of amorphous form of a drug,
WO2005/117837A1 (2005).
[40] A. M. Abdul-Fattah, D. Lechuga-Ballesteros, D. S. Kalonia, M. J. Pikal, The
impact of drying method and formulation on the physical properties and stability of
-References-
56
methionyl human growth hormone in the amorphous solid state, J. Pharm. Sci.  97
(2008) 163-184.
[41] F. Igantious, L. Sun, Electrospun amorphous pharmaceutical compositions,
WO2004014304A2 (2003).
[42] K. S. Suslick, G. J. Price, Applications of ultrasound to materials chemistry, Annu.
rev. Mater. Sci.  29 (1999) 295-326.
[43] G. Ruecroft, D. Hipkiss, T. Ly, N. Maxted, P. W. Cains, Sonocrystallization: The
use of ultrasound for improved industrial crystallization, Org. Process Res. Dev.  9
(2005) 923-932.
[44] T. Yamaguchi, M. Nishimura, R. Okamoto, T. Takeuchi, K. Yamamoto, Glass
formation of 4"-O-(4-methoxyphenyl) acetyltylosin and physicochemical stability of
the amorphous solid, Int. J. Pharm.  85 (1992) 87-96.
[45] E. Shalaev, G. Zografi, The concept of "structure" in amorphous solids from the
perspective of the paharmaceutical sciences, in: H. Levine, editor Amorphous food
and pharmaceutical systems, Cambridge: The Royal Society of Chemistry, 2002,  pp
11-30.
[46] L. H. Sperling, Introduction to physical polymer science. John Wiley & Sons Inc.
New York., 1992, p 594.
[47] P. W. Anderson, Viewpoint: The future, Science  267 (1995) 1615-1616.
[48] W. Kauzmann, The nature of the glassy state and the behavior of liquids at low
temperatures, Chem. Rev.  43 (1948) 219-256.
[49] N. E. Cusack, The physics of structurally disordered matter. An introduction. IOP
Publishing Ltd., Bristol, England, 1987, p 402.
[50] C. T. Moynihan, A. J. Easteal, J. Wilder, Dependence of the glass transition
temperature on heating and cooling rate, J. Phys. Chem.  78 (1974) 2673-2677.
[51] M. D. Ediger, C. A. Angell, S. R. Nagel, Supercooled liquids and glasses, J. Phys.
Chem.  100 (1996) 13200-13212.
[52] K.-L. Li, A. A. Jones, P. T. Inglefield, Domain size of dynamic heterogeneities just
above the glass transition in an amorphous polycarbonate, Macromolecules  22
(1989) 4198-4204.
[53] M. D. Ediger, Movies of the glass transition, Science  287 (2000) 604-605.
[54] L. Slade, H. Levine, Beyond water activity: Recent advances based on an
alternative approach to the assessment of food quality and safety, Crit. Rev. Food
Sci. Nutr.  30 (1991) 115-360.
[55] D. Champion, M. Le Meste, D. Simatos, Towards an improved understanding of
glass transition and relaxations in foods: molecular mobility in the glass transition
range, Trends Food Sci. Tech.  11 (2000) 41-55.
[56] G. W. White, S. H. Cakebread, The glassy state in certain sugar-containing food
products, J. Fd Technol.  1 (1966) 73-82.
[57] Y. Roos, M. Karel, Effect of glass transitions on dynamic phenomena in sugar
containing food systems, in: J. M. V. Blanshard, P. J. Lillford, editors, The glassy state
in foods: Nottingham University Press, England, 1993,  pp 207-222.
[58] Y. H. Roos, S. M. Lievonen, State transitions and reaction rates in concentrated
food systems, in: J. Welti-Chanes, G. V. Barbosa-Canovas, J. M. Aguilera, editors,
Engineering and food for the 21st century: CRC Press LLC, Boca Raton, 2002,  pp
67-86.
[59] J. M. Hutchinson, Physical aging of polymers, Prog. Polym. Sci.  20 (1995) 703-
760.
-References-
57
[60] C. Mao, S. P. Chamarthy, R. Pinal, Time-dependence of molecular mobility
during structural relaxation and its impact on organic amorphous solids: An
investigation based on a calorimetric approach Pharm. Res.  23 (2006) 1906-1917.
[61] M. Le Meste, D. Champion, G. Roudaut, G. Blond, D. Simatos, Glass transition
and food technology: A critical appraisal, J. Food Sci.  67 (2002) 2444-2458.
[62] K.-H. Illers Von, Einfluss der thermischen Vorgeschichte auf die Eigenschaften
von polyvinylchlorid, Makromol. Chemie  127 (1970) 1-33.
[63] J. C. Arnold, The effects of physical aging on the brittle fracture behavior of
polymers, Polym. Eng. Sci.  35 (1995) 165-169.
[64] A. C.-M. Yang, R. C. Wang, J. H. Lin, Ductile-brittle transition induced by aging
in poly(phenylene oxide) thin films, Polymer  37 (1996) 5751-5754.
[65] S. Mukherjee, S. A. Jabarin, Aging characteristics of oriented poly(ethylene
terephthalate), Polym. Eng. Sci.  35 (1995) 1145-1154.
[66] L. W. Vick, R. G. Kander, Physical aging effects in the compaction and sintering
of polycarbonate powder,  Plastics- Rasing into the future: Society of plastics
engineers, 1996,  pp 1960-1964.
[67] V.-T. Truong, B. C. Ennis, Effect of physical aging on the fracture behavior of
crosslinked epoxies, Polym. Eng. Sci.  31 (1991) 548-557.
[68] S. Vyazovkin, I. Dranca, Effect of physical aging on nucleation of amorphous
indomethacin, J. Phys. Chem. B  111 (2007) 7283-7287.
[69] A. Tanaka, K.-h. Nitta, R. Maekawa, T. Masuda, T. Higashimura, Effects of
physical aging on viscoelastic and ultrasonic properties of poly[1-(trimethylsilyl)-1-
propyne] films, Polym. J.  24 (1992) 1173-1180.
[70] A. M. Abdul-Fattah, K. M. Dellerman, R. H. Bogner, M. J. Pikal, The effect of
annealing on the stability of amorphous solids: Chemical stability of freeze-dried
moxalactam, J. Pharm. Sci.  96 (2007) 1237-1250.
[71]  M.  J.  Pikal,  R.  D.  Reddy,  E.  Y.  Shalaev,  C.  B.  Ziegler,  Method  of  stabilizing
disordered cefovecin sodium salt, WO2005/102274 A2 (2005).
[72] R. D. Reddy, E. Y. Shalaev, R. M. Shanker, C. B. Ziegler, Process for annealing
amorphous atorvastatin, CA2547216A1 (2005).
[73] B. C. Hancock, S. L. Shamblin, G. Zografi, Molecular mobility of amorphous
pharmaceutical solids below their glass transition temperatures, Pharm. Res.  12
(1995) 799-806.
[74] C. Bhugra, M. J. Pikal, Role of thermodynamic, molecular, and kinetic factors in
crystallization from the amorphous state, J Pharm. Sci.  97 (2008) 1329-1349.
[75] S. R. Ovshinsky, Chemistry and structure in amorphous materials: The shapes of
things to come, in: D. Adler, H. Fritzsche, S. R. Ovshinsky, editors, Physics of
disordered materials: Plenum Press, New York, USA, 1985,  pp 37-54.
[76] S. D. Allison, B. Chang, T. W. Randolph, J. F. Carpenter, Hydrogen bonding
between sugar and protein is responsible for inhibition of dehydration-induced
protein unfolding, Arch. Biochem. Biophys.  365 (1999) 289-298.
[77] E. Fukuoka, M. Makita, S. Yamamura, Glassy state of pharmaceuticals. III.
Thermal properties and stability of glassy pharmaceuticals and their glass systems,
Chem. Pharm. Bull.  37 (1989) 1047-1050.
[78] Ö. Almarsson, M. J. Zaworotko, Crystal engineering of the composition of
pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to
improved medicines?, Chem. Commun.  (2004) 1889-1896.
[79] D. L. Price, Intermediate-range order in glasses, Curr. Opin. Solid State Mater.
Sci.  1 (1996) 572-577.
-References-
58
[80] S.-J. Kim, T. E. Karis, Glass formation from low molecular weight organic melts,
J. Mater. Res.  10 (1995) 2128-2136.
[81] G. Van den Mooter, M. Wuyts, N. Blaton, R. Busson, P. Grobet, P. Augustijns, R.
Kinget, Physical stabilisation of amorphous ketoconazole in solid dispersions with
polyvinylpyrrolidone K25, Eur. J. Pharm. Sci.  12 (2001) 261-269.
[82] J. L. Keddie, R. A. L. Jones, R. A. Cory, Interface and surface effects on the glass-
transition temperature in thin polymer films, Faraday Discuss.  98 (1994) 219-230.
[83] E. Fukuoka, M. Makita, S. Yamamura, Some physicochemical properties of
glassy indomethacin, Chem. Pharm. Bull.  34 (1986) 4314-4321.
[84] A. R. Paradkar, B. Chauhan, B. Yamamura, A. P. Pawar, Preparation and
characterization of glassy celecoxib, Drug Dev. Ind. Pharm.  29 (2003) 739-744.
[85] G. S. Parks, H. M. Huffman, F. R. Cattoir, Studies on glass.  II. The transition
between the glassy and liquid states in the case of glucose, J. Phys. Chem.  32 (1928)
1366-1379.
[86] K. C. Fox, Putting proteins under glass, Science  267 (1995) 1922-1923.
[87] Y. Guo, S. R. Byrn, G. Zografi, Physical characteristics and chemical degradation
of amorphous quinapril hydrochloride, J. Pharm. Sci.  89 (2000) 128-143.
[88] S. Yoshioka, Y. Aso, Correlations between molecular mobility and chemical
stability during storage of amorphous pharmaceuticals, J. Pharm. Sci.  96 (2007) 960-
981.
[89] E. Vittadini, P. Chinachoti, J. P. Lavoie, X. Pham, Correlation of microbial
response in model food systems with physico-chemical and "mobility" descriptors of
the media, Innov. Food Sci. Emerg. 6 (2005) 21-28.
[90] N. Okamoto, M. Oguni, Discovery of crystal nucleation proceedings much below
the glass transition temperature in a supercooled liquid, Solid State Commun.  99
(1996) 53-56.
[91] Y. Roos, M. Karel, Crystallization of amorphous lactose, J. Food Sci.  57 (1992)
775-777.
[92] I. Alig, D. Braun, R. Landgendorf, M. Voigt, J. H. Wendorff, Simultaneous ageing
and crystallization processes within the glassy state of a low molecular weight
substance, J. Non-Cryst. Sol.  221 (1997) 261-264.
[93] C. Mao, S. P. Chamarthy, S. R. Byrn, R. Pinal, A calorimetric method to estimate
molecular mobility of amorphous solids at relatively low temperatures, Pharm. Res.
23 (2006) 2269-2276.
[94] G. Adam, J. H. Gibbs, On the temperature dependence of cooperative relaxation
properties in glass-forming liquids, J. Chem. Phys.  43 (1965) 139-146.
[95] I. M. Hodge, Effects of annealing and prior history on enthalpy relaxation in
glassy polymers. 6. Adam-Gibbs formulation of nonlinearity, Macromolecules  20
(1987) 2897-2908.
[96] R. Böhmer, K. L. Ngai, C. A. Angell, D. J. Plazek, Nonexponential relaxations in
strong and fragile glass formers, J. Chem. Phys.  99 (1993) 4201-4209.
[97] K. J. Crowley, G. Zografi, The use of thermal methods for predicting glass-
former fragility, Thermochim. Acta  380 (2001) 79-93.
[98]  Q. Lu,  G.  Zografi,  Properties  of  citric  acid at  the glass  transition,  J.  Pharm. Sci.
86 (1997) 1374-1378.
[99] D. Q. M. Craig, P. G. Royall, V. L. Kett, M. L. Hopton, The relevance of the
amorphous state to pharmaceutical dosage forms: glassy drugs and freeze dried
systems, Int. J. Pharm.  179 (1999) 179-207.
-References-
59
[100] S. L. Shamblin, E. Y. Huang, G. Zografi, The effects of co-lyophilized polymeric
additives on the glass transition temperature and crystallization of amorphous
sucrose, J. Therm. Anal.  47 (1996) 1567-1579.
[101] S. L. Shamblin, L. S. Taylor, G. Zografi, Mixing behavior of colyophilized binary
systems, J. Pharm. Sci.  87 (1998) 694-701.
[102] L. Yu, S. M. Reutzel-Edens, C. A. Mitchell, Crystallization and polymorphism of
conformationally flexible molecules: Problems, patterns, and strategies, Org. Process
Res. Dev.  4 (2000) 396-402.
[103]  J.  F.  Carpenter,  S.  C.  Hand,  L.  M.  Crowe,  J.  H.  Crowe,  Cryoprotection  of
phosphofructokinase with organic solutes: Characterization of enhanced protection
in the presence of divalent cations, Arch. Biochem. Biophys.  250 (1986) 505-512.
[104] B. S. Chang, B. S. Kendrick, J. F. Carpenter, Surface-induced denaturation of
proteins during freezing and its inhibition by surfactants, J Pharm. Sci.  85 (1996)
1325-1330.
[105] P. Rongère, N. Morel-Desrosiers, J.-P. Morel, Interactions between cations and
sugars. Part 8.—Gibbs energies, enthalpies and entropies of association of divalent
and trivalent metal  cations with xylitol  and glucitol  in water  at  298.15 K,  J.  Chem.
Soc., Faraday Trans.  91 (1995) 2771 - 2777.
[106] Y. You, R. D. Ludescher, The effect of sodium chloride on molecular mobility in
amorphous sucrose detected by phosphorescence from the triplet probe erythrosin
B, Carbohydr. Res.  343 (2008) 350-363.
[107] R. B. Singh, P. M. Kumar, R. Malik, Formulations of atorvastatin stabilized with
alkali metal additions, EP1336405A1 (2003).
[108] D. Morineau, C. Alba-Simionesco, Hydrogen-bond-induced clustering in the
fragile glass-forming liquid m-toluidine: Experiments and simulations, J. Chem. Phys.
109 (1998) 8494-8503.
[109] R. J. Timko, Thermal characterization of glass dispersion systems, ed., Rutgers,
The state university of New Jersey-New Brunswick, Rutgers, The State University of
New Jersey-New Brunswick, 1979  p 197.
[110] H. Kageyama, K. Itano, W. Ishikawa, Y. Shirota, Striking effects of halogen
substituents on the glass properties, glass transition temperatures and stabilities of
the glassy state of a new family of amorphous molecular materials, 1,3,5- tris (4-
halogenophenylphenyloamino)benzenes, J. Mater. Chem.  6 (1996) 675-676.
[111] P. Tong, L. S. Taylor, G. Zografi, Influence of alkali metal counterions on the
glass transition temperature of amorphous indomethacin salts, Pharm. Res.  19
(2002) 649-654.
[112] E. Y. Shalaev, Q. Lu, M. Shalaeva, G. Zografi, Acid-catalyzed inversion of
sucrose in the amorphous state at very low levels of residual water, Pharm. Res.  17
(2000) 366-370.
[113] Y. Song, R. L. Schowen, R. T. Borchardt, E. M. Topp, Effect of pH on the rate of
asparagine deamidation in polymeric formulations: pH-rate profile, J. Pharm. Sci.  90
(2001) 141-156.
[114] Y. Chikaraishi, M. Otsuka, Y. Matsuda, Preparation of amorphous and
polymorph piretanide and their physicochemical properties and solubilities, Chem.
Pharm. Bull.  44 (1996) 1614-1617.
[115] G. Chawla, A. K. Bansal, A comparative assessment of solubility advantage
from glassy  and  crystalline  forms  of  a  water-insoluble  drug,  Eur.  J.  Pharm.  Sci.   32
(2007) 45-57.
[116] H. Konno, L. S. Taylor, Influence of different polymers on the crystallization
tendency of molecularly dispersed amorphous felodipine, J. Pharm. Sci.  95 (2006)
2692-2705.
-References-
60
[117] P. Marsac, H. Konno, L. S. Taylor, A comparison of the physical stability of
amorphous felodipine and nifedipine systems, Pharm. Res.  23 (2006) 2306-2316.
[118] D. Zhou, G. G. Z. Zhang, D. Law, D. J. W. Grant, E. A. Schmitt, Physical stability
of amorphous pharmaceuticals: Importance of configurational thermodynamic
quantities and molecular mobility, J. Pharm. Sci.  91 (2002) 1863-1872.
[119] D. Law, S. L. Krill, E. A. Schmitt, J. J. Fort, Y. Qiu, W. Wang, W. R. Porter,
Physicochemical considerations in the preparation of amorphous ritonavir-
poly(ethylene glycol) 8000 solid dispersion, J. Pharm. Sci.  90 (2001) 1015-1025.
[120] K. Six, G. Verreck, J. Peeters, P. Augustijns, R. Kinget, G. Van den Mooter,
Characterization of glassy itraconazole: a comparative study of its molecular mobility
below Tg with that of structural analogues using MTDSC, Int. J. Pharm.  213 (2001)
163-173.
[121] T. Miyazaki, S. Yoshioka, Y. Aso, T. Kawanishi, Crystallization rate of
amorphous nifedipine analogues unrelated to the glass transition temperature, Int. J.
Pharm.  336 (2007) 191-195.
[122] D. Kilcast, C. Roberts, Perception and measurements of stickiness, J. Texture
Stud.  29 (1998) 81-100.
[123] B. Adhikari, T. Howes, B. R. Bhandari, V. Truong, Stickiness in foods: A review
of mechanism and test methods, Int. J. Food Prop.  4 (2001) 1-33.
[124] E. M. Petrie, Handbook of adhesives and sealants. McGraw-Hill, New York,
USA, 2000, p 914.
[125] H. Schubert, Food particle technology. Part I: Properties of particles and
particulate food systems, J. Food Eng.  6 (1987) 1-32.
[126] H. Rumpf, Grundlagen und methoden des granulierens, Chem. Eng. Tech.  30
(1958) 144-158.
[127] R. Kunzig, The physics of... tape Why does it stick?, Discover  July (1999) 27-
29.
[128] C. Gay, L. Leibler, Theory of tackiness, Phys. Rev. Let.  82 (1999) 936-939.
[129] B. Bhandari, T. Howes, Proceedings of International Conference on Innovations
in Food Processing Technology and Engineering, Bangkok, Thailand, 2002.
[130] J. M. Aguilera, J. M. del Valle, M. Karel, Caking phenomena in amorphous
food powders, Trends Food Sci. Technol.  6 (1995) 149-155.
[131] B. R. Bhandari, T. Howes, Implication of glass transition for the drying and
stability of dried foods, J. Food Eng.  40 (1999) 71-79.
[132]  G.  E.  Dowton,  J.  L.  Flores-Luna,  J.  King,  Mechanism  of  stickiness  in
hygroscopic, amorphous powders, Ind. Eng. Chem. Fundam.  21 (1982) 447-451.
[133] P. R. Rennie, X. D. Chen, C. Hargreaves, A. R. Meckereth, A study of the
cohesion of dairy powders, J. Food. Eng.  39 (1999) 277-284.
[134] Y. Roos, M. Karel, Plasticizing effect of water on thermal behavior and
crystallization of amorphous food models, J. Food Sci.  56 (1991) 38-43.
[135] C. Hennings, T. K. Kockel, T. A. G. Langrich, New measurements of the sticky
behavior of skim milk powder, Drying Technol.  19 (2001) 471-484.
[136] K. R. Morris, U. J. Griesser, C. J. Eckhardt, J. G. Stowell, Theoretical approaches
to physical transformations of active pharmaceutical ingredients during
manufacturing processes, Adv. Drug Del. Rev.  48 (2001) 91-114.
[137] S. E. Walker, J. A. Ganley, K. Bedford, T. Eaves, The filling of molten thixotropic
formulations into hard gelatin capsules, J. Pharm. Pharmacol.  6 (1980) 389-393.
[138] R. Ritter, Keep cool with cryogenic grinding, Chem. Eng.  104 (1997) 88-93.
[139] M. Wilczek, J. Bertling, D. Hintemann, Optimised technologies for cryogenic
grinding, Int. J. Miner. Process.  74S (2004) 425-434.
-References-
61
[140] M. Peleg, M. Hollenbach, Flow conditioners and anticaking agents, Food
Technology  38 (1984) 93-102.
[141] G. Buckton, P. Darcy, The influence of additives on the recrystallisation of
amorphous spray dried lactose, Int. J. Pharm.  121 (1995) 81-87.
[142] B. C. Hancock, S. L. Shamblin, Water vapour sorption by pharmaceutical
sugars, Pharm. Sci. Technol. To.  1 (1998) 345-351.
[143] M. J. Pikal, K. M. Dellerman, M. L. Roy, R. M. Riggin, The effects of formulation
variables on the stability of freeze -dried human growth hormone, Pharm. Res.  8
(1991) 427-436.
[144] S. Tsourouflis, J. M. Flink, M. Karel, Loss of structure in freeze-dried
carbohydrates solutions: Effect of tmperature, moisture content and composition, J.
Sci. Fd Agric.  27 (1976) 509-519.
[145] B. R. Bhandari, N. Datta, R. Crooks, T. Howes, S. Rigby, A semi-empirical
approach to optimise the quantity of drying aids required to spray dry sugar-rich
foods, Drying Technol.  15 (1997) 2509-2525.
[146]  D.  Q.  M.  Craig,  The  mechanisms  of  drug  release  from  solid  dispersions  in
water-soluble polymers, Int. J. Pharm.  231 (2002) 131-144.
[147] C. Karlsson, P. J. Lundberg, A. Rosinski, M. Soderbom, Polyethylene glycol
matrix pellets for greasy, oily or sticky drug substances, US 6,555,138 B1. (2004).
[148] P. Chiesi, L. Pavesi, pharmaceutical compositions containing ipriflavone, rrocess
for the preparation thereof and relative therapeutic use, EP0521057B1 (1991).
[149] S. Yanai, K. Sudo, Y. Akiyama, N. Nagahara, Oral composition of fumagillol
derivative, US5846562 (1997).
[150] A. J. Humberstone, W. N. Charman, Lipid-based vehicles for the oral delivery of
poorly water soluble drugs, Adv. Drug Del. Rev.  25 (1997) 103-128.
[151] J. Breitenbach, J. Rieger, J. Rosenberg, Long-Shelf-life medicaments, WO
96/29060 (1995).
[152] J. Rosenberg, G. Berndl, B. Liepold, J. Breitenbach, Mechanically stable
pharmaceutical presentations form containing liquid or semisolid surface-active
substances, US 6599528B1 (2000).
[153] S. Host, J. Tsai, Use of oil adsorbent natural polymer for cosmetic and
pharmaceutical applications, EP0659403A2 (1994).
[154] B. Breton, T. Mikolajczyk, F. Ollevier, I. Roelants, Oral delivery form having a
high absorption efficiency and methods for making same, WO97/40702 (1996).
[155] E. Perrier, C. Buffevant, Polysaccharide wall microcapsules containing primary
alcohol functions and compositions containing same, US005562924A (1993).
[156] K. Kumabe, H. Yanaka, T. Kondo, J. Shirai, Stabilizing agent for aleaginous,
physiologically active substances, US005853761A (1996).
[157] K. Kumabe, Core substance-containing calcium microparticles and methods for
producing the same, US00615904A (1999).
[158] A. Shoh, Industrial applications of ultrasound- A review. I. High-power
ultrasound, IEEE Trans. Sonics and Ultrasonics  22 (1975) 60-71.
[159] N. Denbow, Ultrasonic instrumentation in the food industry, in: E. Kress-
Rogers, C. J. B. Brimelow, editors, Instrumentation and Sensors for the Food Industry
(2nd Edition): Woodhead Publishing and CRC Press LCC, USA., 2001,  pp 326-354.
[160] J. D. McClements, Advances in the application of ultrasound in food analysis
and processing, Trends. Food Sci. Technol.  6 (1995) 293-299.
[161] T. J. Mason, Sonochemistry. New York, Oxford University Press, 1999, p 92.
[162] J. R. Frederick, Ultrasonic engineering. John Wiley & Sons,Inc., USA., 1965, p
382.
-References-
62
[163] M. Levina, M. H. Rubinstein, The effect of ultrasonic vibration on the
compaction caharacteristics of paracetamol, J. Pharm. Sci.  89 (2000) 705-723.
[164] N. Passerini, B. Albertini, B. Perissutti, L. Rodriguez, Evaluation of melt
granulation and ultrasonic spray congealing as techniques to enhance the dissolution
of praziquantel, Int. J. Pharm.  318 (2006) 92-102.
[165] A. Mulet, J. Cárcel, J. Benedito, C. Rosselló, S. Simal, Ultrasonic mass transfer
enhancement in food processing, in: J. Welti-Chanes, J. F. Vélez-Ruiz, G. V. Barbosa-
Cánovas, editors, Transport phenomena in food processing: CRC press LLC , USA.,
2003,  pp chp. 18.
[166] D. Knorr, M. Zenker, V. Heinz, L. Dong-Un, Applications and potential of
ultrasonics in food processing, Trends. Food Sci. Technol.  15 (2004) 261-266.
[167] S.-J. Liu, Y.-E. Tsai, S. Wen-Neng Ueng, E.-C. Chan, A novel solvent-free
method for the manufacture of biodegradable antibiotic-capsules for a long-term
drug release using compression sintering and ultrasonic welding techniques,
Biomaterials  26 (2005) 4662-4669.
[168] M. Midler Jr., Production of crystals in a fluidized bed with ultrasonic
vibrations, US3510266 (1970).
[169] V. S. Moholkar, M. M. C. G. Warmoeskerken, Investigation in mass transfer
enhancement in textiles with ultrasound, Chem. Eng. Sci.  59 (2004) 299-311.
[170] H. Kim, J. G. Ryu, H. Yang, J. W. Lee, Compatiblization of PC-San blends by
ultrasound-assisted mixing, Antec  (2003) 2333-2337.
[171] W. Beckham, J. Good, J. Zhan, Dilation of polymeric amorphous regions, ed.,
National textile center annual report, 1996  p 146-147.
[172] J. Stor-Pellinen, E. Hæggström, M. Luukkala, Measurement of the effect of
high-power ultrasound on wetting of paper, Ultrasonics  38 (2000) 953-959.
[173] M. Breitbach, D. Bathen, Influence of ultrasound on adsorption processes,
Ultrason. Sonochem.  8 (2001) 277-283.
[174] J. D. Floros, H. Liang, Acoustically assisted diffusion through membranes and
biomaterials, Food Technol.  48 (1994) 79-84.
[175] T. Iwasaki, B. Lindberg, H. Meier, The effect of ultrasonic treatment on
individual food fibres, Svensk Papperstidning  20 (1962) 795-816.
[176] S. Guo, Y. Li, G. Chen, H. Li, Ultrasonic improvement of rheological and
processing behaviour of LLDPE during extrusion, Polym. Int.  52 (2003) 68-73.
[177] T. J. Mason, Power ultrasound in food processing, in: M. J. W. Povey, T. J.
Mason, editors, Ultrasound in food processing: Blackie Academic & Professional,
Great Brittain, 1998,  pp 105-126.
[178] F. F. Rawson, An introduction to ultrasonic food cutting, in: M. J. W. Povey, T.
J. Mason, editors, Ultrasound in food processing: Blackie Academic & Professional,
Great Brittain, 1998,  pp 254-269.
[179] T. A. Emam, A. Cuschieri, How safe is high-power ultrasonic dissection?, Ann.
Surg.  237 (2003) 186-191.
[180] Y. Schneider, S. Zahn, J. Hofmann, M. Wecks, H. Rohm, Acoustic cavitation
induced by ultrasonic cutting devices: A preliminary study, Ultrason. Sonochem.  13
(2006) 117-120.
[181] P. Hoppu, New pharmaceutical cutting method, Patent Application No.
60/979895, USA (2007).
[182] R. J. Barnes, M. S. Dhanoa, S. J. Lister, Standard normal variate transformation
and de-trending of near-infrared diffuse reflectance spectra, Appl. Spectrosc.  43
(1989) 772-777.
-References-
63
[183] G. Nichols, C. S. Frampton, Physicochemical characterization of the
orthrorombic polymorph of paracetamol crystallized from solution, J. Pharm. Sci.  87
(1998) 684-693.
[184] G. Roelofsen, J. A. Kanters, Citric acid monohydrate, Cryst. Struct. Comm.  1
(1972) 23-26.
[185] J. P. Glusker, J. A. Minkin, A. L. Patterson, X-ray crystal analysis of the
substrates of aconitase. IX. A refinement of the structure of anhydrous citric acid,
Acta Cryst. B  25 (1969) 1066-1072.
[186]  R.  L.  Shriner,  S.  G.  Ford,  L.  J.  Roll,  Itaconic  anhydride  and  itaconic  acid,  Org.
Synth.  11 (1931) 70.
[187] R. L. Shriner, S. G. Ford, L. J. Roll, Citraconic anhydride and citraconic acid,
Org. Synth.  11 (1931) 28.
[188] M. P. Summers, R. P. Enever, Glass transition temperature of citric acid, J.
Pharm. Sci.  69 (1980) 612-613.
[189] V. Truong, B. R. Bhandari, T. Howes, B. Adhikari, Analytical model for the
prediction of glass transition temperature of food systems, in: H. Levine, editor
Amorphous food and pharmaceutical systems, Cambridge: The Royal Society of
Chemistry, 2002,  pp 31-47.
[190] A. Beuford, Amorphous drug beads, US7163700 B2 (2002).
[191] L. N. Bell, T. P. Labuza, Moisture sorption. Practical aspects of isotherm
measurement and use. The American Association of Cereal Chemists Inc., USA.,
2000, p 122.
[192] V. Andronis, M. Yoshioka, G. Zografi, Effects of sorbed water on the
crystallization of indomethacin from the amorphous state, J. Pharm. Sci.  86 (1997)
346-351.
[193] A. Salameh, L. S. Taylor, Role of deliquescence lowering in enhancing chemical
recativity in physical mixtures J. Phys. Chem. B  110 (2006) 10190-10196.
[194] T. E. Karis, S. J. Kim, P. L. Gendler, Y. Y. Cheng, Organic monomeric glass
formation by substituted ethylenediamine, J. Non-Cryst. Sol.  191 (1995) 293-303.
[195] J. Petravic, J. Delhommele, Hydrogen bonding in ethanol under shear, J. Chem.
Phys.  122 (2005) 1-5.
[196] P. Sherman, Industrial rheology with particular reference to foods,
pharmaceuticals and cosmetics. Academic Press, London, UK, 1970, p 423.
[197] R. Pal, Y. Yan, J. H. Masliyah, Rheology of emulsions, in: L. L. Schramm, editor
Emulsions: Fundamentals and applications in the petroleum industry, Washington:
American Chemical Society, Washington DC, USA, 1992,  pp 131-170.
[198] R. J. Hunter, Foundations of colloid science Oxford University Press, Oxford,
UK, 1986, p.
[199] G. P. Johari, S. Kim, R. M. Shanker, Dielectric studies of molecular motions in
amorphous solid and ultraviscous acetaminophen, J. Pharm. Sci.  94 (2005) 2207-
2223.
[200] V. Andronis, G. Zografi, The molecular mobility of supercooled amorphous
indomethacin as a function of temperature and relative humidity, Pharm. Res.  15
(1998) 835-842.
[201] C. A. Angell, D. Bressel, R. Green, J. L. Kenno, M. Oguni, E. J. Sare, Liquid
fragility and the glass transition in water and aqueous solutions, J. Food Eng.  22
(1994) 115-142.
[202] Y. Aso, S. Yoshioka, T. Miyazaki, T. Kawanishi, K. Tanaka, S. Kitamura, A.
Takakura, T. Hayashi, N. Muranush, Miscibility of nifedipine and hydrophilic polymers
as measured by 1H-NMR spin–lattice relaxation, Chem. Pharm. Bull.  55 (2007) 1227-
1231.
-References-
64
[203] P. I. Buler, Thermodynamic criteria of crystallization from supercooled liquid,
Ceram. Int.  16 (1990) 165-169.
[204] M. T. Cicerone, A. Tellington, L. Trost, A. Sokolov, Substantially improved
stability of biological agents in dried form, BioProcess International  1 (2003) 36-47.
[205] T. R. Noel, R. Parker, S. G. Ring, A comparative study of the dielectric relaxation
behaviour of glucose, maltose, and their mixtures with water in the liquid and glassy
states, Carb. Res.  282 (1996) 193-206.
[206] J. Casulli, J. R. Clermont, The oscillating die: A useful concept in polymer
extrusion, Polym. Eng. Sci.  30 (1990) 1551-1556.
[207] A. Van Hook, F. Frulla, Nucleation in sucrose solutions, Ind. Eng. Chem.  44
(1952) 1305-1308.
